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ABSTRACT
CHARACTERIZATION OF PORCINE RESPIRATORY EPITHELIAL CELLS AND
THEIR INNATE IMMUNE RESPONSES TO BACTERIAL AND VIRAL LIGANDS
YAM PRASAD GAUTAM
2022
In response to a pathogenic attack, the host produces a series of defense mechanisms
through various intracellular signaling pathways. The byproduct of these signaling
pathways helps tackle the invading pathogen and protects the body from getting into a
diseased state. This system is called the immune system. The immune system can be
divided into two branches namely the innate immune system and adaptive immune system.
The groups of immune cells that provide protection regardless of the pathogen specificity
constitute the innate immune system. The system that acts according to the pathogen
specificity is called the adaptive immune response. The production of antibodies by B cells
is a prime example of adaptive immune responses. Macrophages, neutrophils, and
monocytes are a few examples of innate immune cells. Besides them, mucosal epithelial
cells of the intestinal and respiratory systems are crucial in generating innate immune
responses. Invading pathogens and their recognition by the host is pivotal in preventing the
subsequent infection and diseases. Epithelial cells express various Pathogen Recognition
Receptors (PRRs). These PRRs recognize pathogen-associated molecular patterns
(PAMPs) or damage-associated molecular patterns (DAMPs). The binding of PAMPs
and/or DAMPs to epithelial cells initiates intracellular signaling pathways that lead to the
generation of innate immune responses through the regulation of gene expression. Porcine
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respiratory epithelial cells and their expression of PRRs render them vital not only for the
regulation of innate immune responses but also to study respiratory disease pathogenesis.
Ironically, only a handful of studies can be found on these cells and the limited number of
studies have hindered our understanding of the role of porcine respiratory cells in innate
immunity.
In this study, we have characterized previously established porcine primary respiratory
epithelial cells from nasal turbinate and trachea followed by their immortalization using
hTERT and SV40 large T-antigen. We also studied their innate immune responses to
various bacterial and viral ligands. Both the primary and immortalized cells showed typical
epithelial cobblestone morphology with a heavy expression of cytokeratin indicating
epithelial origin. Cells did not change their morphological characteristics even after
immortalization. Immortalization was confirmed by immunofluorescence assay for SV40
and immunocytochemistry for hTERT. However, they did look more granulated than the
primary cells. Growth curve analysis showed a faster growth rate of immortalized cells in
comparison to the primary cells of both nasal and tracheal origin. Finally, we stimulated
the primary cells with various bacterial and viral ligands. Upon stimulation, porcine
primary respiratory cells mounted innate immune responses through modulation of the
expression of various PRRs and the production of cytokines/chemokines. Modulation of
gene expression on mRNA level was measured using ΔΔct method. The research findings
may be vital in studying the role of respiratory epithelial cells in the pathogenesis of various
respiratory diseases and innate immune responses in pigs.
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1

Chapter 1. Literature review

1.1 Mucosal surfaces and innate immunity
The mucosal surfaces of the body play a major role in innate immunity and host-pathogen
interaction. The importance of the involvement of respiratory and intestinal mucosa and
the epithelial surfaces in the host-pathogen interaction, anatomical and physiological
barrier function as the first line of defense has been shown by overwhelming number of
previous studies (1-4). Microorganisms are received by the digestive and respiratory
mucosal epithelia mostly via ingestion/inhalation. The epithelial surfaces have unique
receptors for the binding of pathogens and their entry. The unique receptors on the
epithelial cell surfaces are called Pathogen Recognition Receptors (PRRs) that bind to
specific Pathogen Associated Molecular Patterns (PAMPs) on microbe surfaces. The
binding of PRRs to PAMPs initiates cell signaling followed by the activation of the innate
immune responses (5, 6).
Intestinal and respiratory mucosal epithelial cells are continuously exposed to various
microorganisms. All microbes are not pathogens because the commensals or the normal
flora are the populations of microbes that benefit the host and do not have any pathogenic
action toward the host (7, 8). The epithelial cells can sense the presence of pathogens or
their metabolic products and mount the immunological responses against them while
simultaneously inducing tolerance against the commensals which is a basis for balance and
homeostasis. The sensing of pathogens or commensals is highly regulated as it is a way of
knowing the microbial environment and the surrounding (9). The selective recognition of
pathogens and the distinction between pathogens and commensals by the host is believed
to be there because the surface epithelia cause the sequestration of indigenous microflora
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and thus, the PRRs cannot be activated whereas the antigens/virulence factors on pathogens
easily pass-through epithelial barriers and recognized by various PRRs on immune cells
(10, 11).
1.1.1

Immune system and its components

To protect or defend us, a well-specialized and organized system exists that plays a role
against infection, and this organized system is known as the immune system. The Immune
system can fundamentally be differentiated into two branches. The innate immune system
protects by using various innate immune cells like macrophages, neutrophils, and
monocytes which are phagocytic and perform phagocytosis (12). Other cells including
mast cells, NK-cells, basophils, and eosinophils are also components of the innate immune
system and help in producing innate inflammatory responses to provide defense against
infection by invading microbes. B cells and T cells are the major components of the
adaptive immune system, the second branch of the immune system. The adaptive immune
system is responsible for the humoral or antibody-based immune response against microbes
(13). The innate immune system and its response play an important role in the removal of
pathogens and in developing pathogen-specific adaptive immunity (14). Both branches of
the immune system come together and work simultaneously and defend us against
pathogens (5).
1.2 Pathogen recognition receptors
The invasion of a host by microorganisms initiates their recognition through germlineencoded receptors which are known as the pattern-recognition receptors (PRRs) (15). PRRs
exist in a variety of classes and have a diverse range of immunological functionality. TLRs,
NLRs, and RLRs are some common examples of PRRs. PRRs bind to their respective
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ligands which lead to the activation of intracellular signaling and subsequent expression or
upregulation of genes that are vital for the generation of immune responses (16-18).
Microbial components recognized by PRRs are called pathogen-associated molecular
patterns (PAMPs). PAMPs are essential molecules that are required by pathogens for their
survival. Different PAMPs are recognized by their respective PRRs and this binding
activates specific signaling pathways to generate distinct antipathogenic responses (19).
1.2.1

Toll-like receptors

1.2.1.1 History
Out of several kinds of PRRs such as Toll-Like Receptors (TLRs), NOD-like receptors
(NLRs), RIG-I like receptors (RLRs), C-type lectin receptors, absent in melanoma 2
(AIMS) like receptors, TLRs are the most powerful molecular receptors used by the innate
immune system to sense the microbial environment and provide the necessary protection
to the host. The 2011 Nobel prize award in medicine to Jules Hoffman and Bruce Beutler
tells the impact and worldwide recognition of this landmark finding (20).
TLRs or the toll proteins were first identified in Drosophila melanogaster (21), and this
discovery is marked as one of the most significant breakthroughs in host-pathogen
interaction which led to a flurry of research and discoveries in the field of immunology.
Initially, Toll receptors were discovered as a transmembrane receptors essential for the
dorso-ventral polarity development in developing embryos of Drosophila (21). Nine genes
in the Drosophila genome encode toll proteins (22). In humans, 10 TLRs have been
identified. Human TLR1, TLR2, TLR3, TLR6, and TLR10 reside on chromosome number
4 while TLR4 and TLR5 reside on chromosomes 9 and 1, respectively. Similarly, TLR7
and TLR8 are in chromosome 10 while chromosome 3 encodes TLR9. The above
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chromosomal locality reveals the dispersed nature of TLR genes throughout the human
genome. TLR genes and their DNA sequence studies have shown the conserved nature of
these genes across species and their independent evolution from a common ancestral gene
(23-25).

5

Figure 1: Microbial components and their recognition by respective TLRs (19).

6

Figure 2: History of TLRs (26). Sequence of events starting from the discovery of TLRs to
their roles in the innate immune system are described in a chronological order.

7

1.2.1.2 Types and distribution
Not long after Drosophila Toll protein was identified for the first time, a similar group of
proteins sharing structural similarities to Toll protein in Drosophila was identified and was
given the name Toll-like receptors (TLRs). TLRs have an extracellular domain with a
leucine-rich repeat (LRR) and an intracellular domain with TIR. Out of all the TLRs
identified to date, TLR4 is the one first identified. Lipopolysaccharide (LPS), a component
of Gram-negative bacterial cell wall, was found to be recognized by TLR4 for the first time
in 1998. This discovery was of immense significance and led to many more findings and
discoveries of TLRs and their recognition of microbial components (21, 27).
Mammalian cells express several TLRs and different TLRs have their own tissue as well
as cell-specific distribution pattern. To date, 13 different TLRs have been identified in
mammals, 10 in humans, 10 in bovine, 10 in ovine, and 13 in mice (19, 28). Based on their
expression TLRs are categorized into transmembrane receptors such as those expressed in
epithelial cellular membranes, for example, TLR1, TLR-2, TLR-5, TLR-6, and those
expressed intracellularly, for example, TLR-3, TLR-7, TLR-8, TLR-9, TLR-11, TLR-12,
and TLR-13. Unlike other TLRs, TLR-4 is expressed extracellularly as well as
intracellularly (29).
The mounting of the dysregulated innate immune response against commensals by the
failure of recognition has been linked to severe diseases like inflammatory bowel disease
and colorectal cancer (30). TLR2, TLR-4, TLR-5, and TLR-9 variants respectively have
been linked to Crohn’s disease and ulcerative colitis (31, 32). In conclusion, mutation,
polymorphism, or any unwanted changes in these receptors have the potential to severely
dysregulate homeostasis. The optimal expression of TLRs on intestinal and respiratory
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epithelial cells is key in protecting the host through the activation of the innate immune
response followed by adaptive immunity (33).
TLRs are categorized into 5 subfamilies on basis of amino acid sequence comparison.
TLR2, TLR3, TLR4, TLR5, and TLR9 are the 5 different subfamilies. Based on their
similarity in amino acid sequence and genomic structures, a phylogenetic tree is
constructed as shown in the figure 3 below (21).
A variety of innate immune cells ubiquitously express mRNAs for TLR expression. Blood
monocytes/macrophages express most TLRs. However, they do not express TLR3 (34).
Mature dendritic cells and immature dendritic cells have different levels of expression of
TLRs. Some TLRs are expressed more in immature cells while some are expressed at high
levels in mature cells. For example, TLR1, 2, 4, and 5 expression is high initially in mature
dendritic cells but as the cells mature, their expression is lowered with the maturity. The
expression of TLRs on dendritic cells can be said to have a direct correlation with the
maturation stages (35). Mast cells, also express TLRs including TLR2, TLR4, TLR6, and
TLR8 (36, 37). The intestinal and respiratory epithelial cells express TLRs, but the
expression is finely regulated and is less widespread when compared to immune cells.
Regulated expression of TLRs on epithelial cells is crucial because immune cells or APCs
are programmed to trigger an immune response against foreign organisms, but if epithelial
cells also elicit an immune response like APCs, it will lead to unnecessary and
overexpression of immune responses against billions of commensals throughout the
mucosal surfaces. Thus, the expression of TLRs is selective and less widespread in mucosal
epithelial cells. When encountered with a pathogen, mucosal epithelial cells can produce
inflammatory cytokines and chemokines such as IL-6, IL-10, IL-1a, IL-1b, IL-13, TNF-a,
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and thus, promote inflammation and protection against the pathogen. Mucosal epithelial
cells can activate the innate and adaptive immune systems by producing factors like
interferons, BAFF, and APRIL (38, 39).
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Figure 3: Phylogenetic tree of Human Toll-like receptors (21). The phylogenetic tree is
designed on basis of genetic resemblances between TLRs.
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1.2.1.3 TLR signaling

Figure 4: TLR signaling pathway (19). The figure shows both the MyD88 dependent
signaling pathway and TRIF dependent signaling pathway leading to the transcription of
proinflammatory cytokines and type-I Interferons.

12

PRRs recognize PAMPs or DAMPs leading to the activation of downstream signaling. The
downstream signaling activates the innate immune system marked by the production of
inflammatory cytokines, chemokines, and IFNs. These molecules not only contribute to
the innate response but also the activation of the pathogen-specific adaptive immune
response. TLRs recognition of PAMPs is facilitated by leucine-rich repeats (LRRs), an
ectodomain of TLRs. TLRs also possess a cytoplasmic Toll/IL-1 receptor (TIR) domain
responsible for the initiation of downstream signaling. Recognition of PAMPs promotes
TIR domain-containing adaptor proteins recruitment by TLRs. Adaptor proteins such as
MyD88 and TRIF commence signal transduction pathway that leads to the activation of
the NF-kB pathway or MAP kinase pathway that regulates the expression of genes
encoding cytokines, chemokines, and IFNs that contribute to the host defense (40-42).
1.2.1.3.1 MyD88 dependent signaling pathway
MyD88, an adaptor molecule central to the inflammatory signaling pathway, was first
described as an upregulated gene during IL-6 induced myeloid differentiation (43, 44).
MyD88 has a C-terminal portion consisting of the TIR domain and interacts with the TIRdomain containing molecules such as TLRs. Death Domain (DD), present in the Nterminus of MyD88, is associated with IL-1 receptor-associated kinase (IRAK). IRAK
activity was described for the first time in 1994 (45). The first cloned IRAK molecule was
IRAK1. But it was found that the mice lacking IRAK1 still were able to respond to IL-1,
even though the response was very weak (46). Later, three other members of the IRAK
family were identified namely IRAK2, IRAK-M, and IRAK4 (44, 47-49). When activated,
IRAK1 undergoes autophosphorylation and interacts with TNF receptor-associated factor
6 (TRAF6). IRAK/TRAF6 interaction assembles a multiprotein signaling complex
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consisting of TAK1, which is the mitogen-activated protein kinase kinase kinase
(MAPKKK) and is associated with TAB1, TAB2, and TAB3 proteins, which are
responsible for the regulation of activation of TAK1 kinase. Activation of TAK1 leads to
the activation of IkB kinases (IKKs), p38, and JNKs, which ultimately leads to the
activation of NF-kB and AP-1. NF-kB is a transcription factor, which translocate from the
cytoplasm into the nucleus and thus, occurs the expression of proinflammatory cytokines
IL-1, IL-6, and TNF-a. AP-1, an activator protein, and a transcription factor, activated via
the MAPK family of proteins that are activated by TAK1, is also responsible for inducing
the expression of innate immune response genes (19, 21, 50, 51).
1.2.1.3.2 TRIF-dependent signaling pathway
Toll/IL-1R domain-containing adaptor-inducing IFN-B or the TRIF-dependent signaling
pathway plays important role in host defense and is responsible for the production of TypeI IFN alongside various mediators of the inflammatory immune response against pathogens
independent of MyD88. TRIF is an adaptor molecule contributing to the activation of IRF3 and subsequent IFN-B production (52, 53).
TICAM-1/TRIF comprises of an N-terminal domain, a TIR-domain, TRAF6-binding
motif, and a receptor-interacting protein homotypic interaction motif (RHIM) (54). TIR
domain of TICAM-1/TRIF binds to the TIR domain of TLR-3 leading to the activation of
IRF-3, a transcriptional factor that later translocate into the nucleus and induces the
production of type-I IFNs. Activation of the NF-kB pathway is believed to occur through
the C-terminal domain (55). But it has been found that TICAM-2, another adaptor molecule
like TICAM-1, is required for TICAM-1 to bind to TLR-4 for the activation of the TLR-4
mediated signaling pathway (52).
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TRIF dependent signaling pathway is both negatively and positively regulated by various
molecules.

Molecules like CD16, CD14, Pellino (E3 ubiquitin ligase), TRIM56, and

TRIM62 positively regulate the pathway by bolstering the activation or inhibiting the
inhibitors of the pathway (56-59). Similarly, molecules like TAG (a TRAM variant),
TRIM38, Pin1(Peptidyl-propyl isomerase), and HDL (High-density lipoprotein)
negatively regulates the TRIF signaling pathway (54, 60-62).
1.2.2

NLRs and RLRs

Nucleotide-binding and oligomerization domain (NOD)-like receptors (NLRs) are another
type of PRRs involved in the activation of NF-kB and MAPK signaling pathways. Unlike
TLRs that recognize PAMPs present on the cell surface or in the endosomes, NLRs
recognize PAMPs in the cytosol (63, 64). The microbial components successful in evading
extracellular detection are detected in the cytosol by NLRs and RIG-like receptors (RLRs).
NLRs are characterized by the presence of a conserved NOD (65). NLRs consist of NOD1 and NOD-2 and are known to recognize products of bacterial peptidoglycan
synthesis/degradation. γ-D-glutamyl-Meso-diaminopimelic acid (iE-DAP) is recognized
by NOD1 while NOD-2 recognizes muramyl dipeptide (MDP) (66, 67).
Structurally, NLRs have a C-terminal leucine-rich repeat (LRR) responsible for the sensing
of microbial particles. This sensing initiates the activation of the N-terminal caspase
recruitment domain (CARD) and pyrin (P). The CARD domain activation leads to the
recruitment of serine-threonine kinase (RICK) and the interaction of NOD1 and NOD2
with RICK induces the NF-kB and MAPK signaling pathway. In cooperation, NF-kB, and
MAPK pathways regulate the innate and adaptive immune responses by upregulating the
production of proinflammatory cytokines (68).
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Like what NOD does, RLRs also recognize PAMPs in the cytoplasm and drive IFNsignaling. More specifically, RLRs interact with viral RNA ligands in the cytoplasm and
contribute to the innate immune system through IFN-B production. Interestingly, RLRs
play role in the adaptive immune response indirectly by driving IFN-B production which
in turn activates B-cells and thus, antibody production (69). RIG-I and MDA-5 are two
main RLRs expressed in a broad variety of cells and play a prominent role in activating the
innate immune system. In addition to IFN-B production, RLRs also trigger the expression
of genes having antiviral properties and play role in inducing antiviral response. In cells,
the expression levels of RLRs differ significantly with or without the viral infection where
the latter induces a high level of expression (70). Structurally, RLRs are like NODs and
have an N-terminal CARD, a central RNA helicase domain involved in the unwinding of
viral RNA molecules, and a C-terminal domain with a repressor domain (RD) within and
is thought to be regulating the autoregulation in RIG-I (70).
According to Cui et al (71), the amino acid sequence ranging from 802-925, in the Cterminal domain, binds to the 5’-triphosphate ends of the viral dsRNA. This binding brings
a conformational change in CARD, which is sequestered from any interaction in absence
of viral infection. The conformational change enables CARD to interact with the adaptor
protein IPS-1. This interaction leads to the phosphorylation of IRF-3 and IRF-7 by TBK1,
subsequent translocation of IRF-3 and IRF-7 into the nucleus, and finally the expression
of genes responsible for IFN-B production (72). RLRs and their signaling are highly
regulated both positively and negatively and destabilization of RLRs signaling has been
linked to various autoimmune disorders and cytokine storms (73).
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1.2.3

Other PRRs

1.2.3.1 C-type lectins
C-type lectins are the type of lectins important in pathogen recognition. They have
carbohydrate recognition domains (CRDs) that bind carbohydrate molecules in a calciumdependent manner (74). C-type lectins are either produced as transmembrane proteins or
are secreted as soluble proteins. Depending on the N-terminus end, they are divided into
type-I and type-II C-type lectins, where the type-II has its N-terminus pointed outside of
the cell cytoplasm and the type-I has its N-terminus towards the cytoplasm (75). Varieties
of C-type lectins exist, and they perform varieties of functions. Transmembrane lectins
have 3 main categories namely selectins mostly important for cell-cell interaction (76),
collectins that are involved in pathogen recognition and innate immunity, and the dendritic
cell-specific ICAM-3 grabbing non-integrin (DC-SIGN), which can act both as cell
adhesion receptor and pathogen recognition receptor (77). C-type lectins contribute to
innate immunity by recognizing the pathogens and their killing by the macrophages. Also,
the antigen processing and presentation to MHC molecules lead to the activation of the
adaptive immune system. Evidence of crosstalk between TLRs and C-type lectins has been
found and this crosstalk is believed to be important in antigen tolerance or immune
response (78, 79).
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1.2.3.2 DNA-binding PRRs
The recognition of CpG DNA by TLR-9 is well known PAMP-PRR interaction for the
induction of immune response against pathogens. However, recent studies have found
several other molecules that can bind DNA and induce the immune response. Absent in
melanoma (AIM2) mediated induction of IL-1B and IL-18 production independent of the
TLR signaling through caspase-1 activation by the assembly of inflammasomes is an
example of such molecules (80). Similarly, RNA polymerase III and DEDX/H box
helicases also activate the NF-kB pathway without relying on TLR signaling (81). DNA
recognition becomes vital in the identification, pathogenesis, and in eliciting of the immune
response against DNA viruses (82).
1.3 Cytokines and Chemokines
Cytokines are protein molecules synthesized by immune cells that are actively involved in
case of an infection or invasion as part of host immune responses. To regulate the host cell
function, cytokines are important molecules that act non enzymatically in nanomolar
concentration. Alongside neurotransmitters and hormones, cytokines are one of the largest
intracellular signaling molecules (83). There are several categories in which cytokines can
be classified. Interleukins are a type of cytokine that is involved in the activation of T cells,
B cells, mast cells, neutrophils, and many other immune cells. Not only activation, but
cytokines also play important role in their growth, development, and differentiation.
Interferons are another class of cytokines that are important in macrophage activation and
antiviral immune responses. Cellular adhesion, cellular response to stimulation, and in
some cases cellular translocations are also controlled by cytokines. Based on inflammatory
properties, cytokines can be divided into two classes. Proinflammatory cytokines are those
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that induce inflammatory responses. IL-1, TNF-α, INF-α, IL-12, and IL-18 are some
examples of proinflammatory cytokines. Anti-inflammatory cytokines are those that
suppress inflammatory responses. Cytokines like IL-4, IL-10, and IL-14 are a few
examples of anti-inflammatory cytokines (84, 85). The target cell membranes have
receptors specific for a cytokine that facilitates their binding, and this receptor binding
activates signal transduction pathways leading to the regulation of gene expression (86).
Chemokines are one of the families of cytokines with a chemoattractant property. They are
vital in cellular trafficking and inflammatory immune response. Chemokines and their
receptors are expressed by a wide variety of immune cells. To date, there are 40 to 50
human chemokines identified. Chemokines are small proteins ranging from 8 to 12 KD in
molecular weight. Chemokines have four major subfamilies mainly C, CXC, CC , and CX3
C. The division into families is based on structural and genetic properties. Mostly all
chemokines are similar in their structure and have at least three β-pleated sheets indicated
as β1-3 and a C-terminal α-helix. Most chemokines possess at least four cysteines in
conserved positions. In the CXC chemokine family, a single amino acid separates the two
cysteines nearest the N-termini of family members. In the CC chemokine family, the two
cysteines nearest the N-termini of these proteins are adjacent. Lymphotactin is a
structurally related chemokine having only one cysteine near its N-terminus and is said to
belong to the C chemokine family. The CX3C chemokine has a typical chemokine-like
structure at its N-terminus except for the placement of three amino acids between the first
two cysteines. IL-8 and MCP-1 are two common examples of chemokines. Apart from
being a chemoattractant, chemokines are actively involved in functions like monocytes and
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neutrophil adhesion, antimicrobial responses, and inflammatory immune responses (87,
88).
1.4 Pig Primary cells for research, and their characteristics
A recent pig heart transplantation into a human in a hospital in Baltimore, Maryland tells
us that pigs have a close resemblance to humans and are immensely important tools not
only for organ transplantation but also for studying human diseases and disease
pathogenesis as a biomedical model.
Compared to other animals, pigs share many physiological and anatomical characteristics
like size, structure, immunology, and genome with humans. The respiratory, digestive,
vascular, and urinary systems of humans and pigs are similar which provides us with the
opportunity to study the immune system in pigs and its significance in humans (89, 90).
Primary cells maintain the genetic and phenotypic characteristics, and functional markers
just like present in in-vivo but, cell lines sometimes lose these properties and could
misrepresent the in-vivo environment. Several examples can be found where the loss of
genetic or phenotypic character is seen on various cell lines, for example, the massspectrometry based comparative study of Hepa1-6 cell line with primary hepatocytes found
that the cell line exhibited a re-arrangement of metabolic pathways with a deficiency in
mitochondria (91, 92). At the same time, maintaining primary cells comes with a challenge
as it is arduous and sensitive. Primary cells and their growth require more effort and care
because primary cells are adapted to live in an in-vivo membrane-bound environment and
their establishment in culture takes time and is extremely sensitive as they need better
optimization of culture conditions and nutrient requirements (93).
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1.4.1

Role of Porcine respiratory epithelium in innate immunity

The epithelial cells of the respiratory mucosal layers act as a physical and immunological
barrier. Antigen-specific mucosal-induced secretory immunoglobin (S-IgA) and ciliary
movement generated by cilia on epithelial cell surfaces for antigen removal are two major
mechanisms for the neutralization of various respiratory infections. Inflammatory
cytokines and Type I IFNs production is another non-specific immune response in
respiratory mucosal surfaces mediated by respiratory epithelial cells (94, 95).
Inflammatory cytokines like IL-1, TNF-α, IL-12 produced in respiratory mucosa are vital
for inflammatory responses against pathogenic infections (84). PRRs and their expression
are vital for not only pathogen recognition, but also subsequent intracellular signaling
processes. The porcine respiratory epithelial cells express various PRRs like TLRs, RLRs,
and NLRs, and help in pathogenic recognition and generation of innate immune responses
through intracellular signaling pathways. Production of cytokines/chemokines by the
epithelial cells in the respiratory mucosa is pivotal for the activation of T cells and B cells,
their maturation, migration, and differentiation (83). Furthermore, the commensal
microorganisms residing in the respiratory mucosa compete with the invading pathogenic
microbes incoming through ingestion/inhalation, for food and shelter and this competition
between the commensals and pathogens sometimes leads to the production of toxins or
metabolic products by the commensals which in turn kill the pathogens benefiting the host
by reducing the chances of new infections. For example, S. salivarius, a commensal
microbe produces bacteriocins, which is antagonistic to S. pneumoniae. Along with
bacteriocins,

it is seen that S. salivarius reduces the S. pneumoniae colonization by

blocking the adhesion sites of S. pneumoniae (96-98).
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1.5 Immortalization of primary cells
The senescence of primary cells after a limited growth duration because of a gradual loss
of telomeric DNA after each cell division is known as the Hayflick Limit (99). Primary
cells have a finite life span and after reaching a certain point, they stop proliferating (100).
A sudden pause in primary cell proliferation may cause an unwanted delay in achieving
research goals. Thus, it becomes immensely important to immortalize the primary cells to
overcome replicative senescence.
The shortening of telomeric DNA is a major cause of primary cell senescence.
Immortalization of primary cells can be done through the introduction of the human
telomerase reverse transcriptase gene (hTERT) or viral oncogenes like the SV40 large Tantigen gene (101). Previous studies have shown that cells can be successfully
immortalized using hTERT or SV40 large T-antigen genes (102, 103). Primary cells
transformed with SV40 large T-antigen genes continue to provide valuable insights of the
cellular behavior with altered expression of oncogenes and inhibition of tumor suppressor
genes. The use of human papillomavirus (HPV) E6 and E7 genes have been seen to achieve
immortalization of primary cells. HPV E6 and E7 genes work in a similar manner to SV40
large T-antigen gene (104). hTERT immortalization introduces the reverse transcriptase
activity that prevents the shortening of the chromosome by the addition of telomeric DNA
at the end of the chromosomes thus, resulting in the continuous proliferating of cells
without replicative senescence (102). One important aspect of immortalization is
preserving the original morphological and phenotypical characteristics. Changes in
phenotypic characteristics after immortalization might render the cells unusable as they
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cannot be trusted to provide the replica of primary cells. It is thus important to characterize
the cells after the immortalization and evaluate any noticeable phenotypic changes.
1.6 Objectives of this study
1. To characterize the established porcine primary and immortalized respiratory
epithelial cells
2. To study the growth kinetics of porcine primary and immortalized respiratory
epithelial cells
3. To study the innate immune responses of porcine primary respiratory epithelial
cells upon stimulation with various bacterial and viral ligands
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2

Characterization of pig primary and immortalized nasal turbinate and tracheal
epithelial cells

2.1 Abstract
Pig primary epithelial cells act as a barrier against various respiratory and enteric
pathogens. Respiratory epithelial cells are means of primary immune defense system
against pathogens by regulating both the innate immune system and the adaptive immune
system. The respiratory epithelial cells mediate inflammatory immune reactions against
pathogens in the respiratory system by producing various inflammatory cytokines like IL1, TNF-α, IL-25, and IL-33 when stimulated by the pathogen. Many airborne pathogens
are inhaled through the respiratory tract. Respiratory epithelial cells provide a physical
barrier and play role in producing cytokines, chemokines, and various other antimicrobial
components to prevent the host from becoming infected. However, the availability of a
limited number of respiratory cell lines has significantly hindered clarity in roles played by
pig primary respiratory epithelial cells in immunity. In this study, we developed and
characterized a primary epithelial cell culture systems originating from the nasal turbinate
and trachea of a day-old gnotobiotic piglet. Growth kinetics and phenotypic properties of
the cells were studied before and after immortalizing the cells using hTERT and/or SV40
large T-antigen-based immortalization method. Overall, we successfully established and
characterized both the primary and immortalized pig nasal turbinate and tracheal epithelial
cell cultures. Both primary and immortalized porcine nasal turbinate and tracheal cells
expressed epithelial cell marker cytokeratin and immortalized porcine nasal turbinate and
tracheal cells showed enhanced growth kinetics with a shorter doubling time compared to
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primary epithelial cells. These cell cultures may serve as a good model for studying hostpathogen interactions and innate immune responses to respiratory pathogens.
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2.2 Introduction
The establishment and use of cell lines in scientific research are not new and have been
employed for several decades. The use of cell lines may be beneficial considering their
easy growth and adaptation to the artificial culture milieu. However, cell lines derived from
various tumors are often susceptible to genotypic and phenotypic drift, and thus, prone to
behave differently in comparison to primary cells (105). Primary cells, on the other hand,
maintain the in-vivo physiological properties and thus, are better suited to be employed in
biological research. Even though primary cells have comparatively limited growth ability
and high mitotic activity, their exact replication of the in-vivo environment is indispensable
in scientific research. The use of primary cells to study the physiological, biological, and
immunological properties of mammals can be found as early as the 1960s (106).
Understanding mucosal immunity in respiratory mucosal surfaces becomes pivotal in
minimizing respiratory diseases and viral infections. Respiratory mucosal surfaces are the
second-largest mucosal surfaces after the digestive tract and thus, respiratory immune
responses and mucosal surfaces are indispensable when it comes to the immune system in
the respiratory tract (107). The respiratory tract can be divided into the upper and lower
parts. The upper respiratory tract consists of the nose, nasal cavities, and pharynx. This part
of the respiratory tract is always in direct exposure to the exterior environment. The lower
respiratory tract consists of mainly the trachea and lungs and is sterile in normal conditions.
The diseased condition is declared when the microbes pass through the upper respiratory
tract, colonize the lower respiratory tract and cause infections. The mucosal surfaces come
into play in preventing or restricting respiratory diseases and viral infections (108).
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There are hundreds of bacteria, viruses, and fungi that can cause respiratory infections.
Viruses like the influenza virus, corona virus, respiratory syncytial virus, parainfluenza
virus, rhinovirus, and adenovirus are some of the most common respiratory viruses and can
cause viral pneumonia. Secondary bacterial infections of the respiratory tract following
viral pneumonia are common and are mostly caused by Streptococcus pneumoniae,
Staphylococcus aureus, Streptococcus pyrogenes, and Haemophilus influenzae. Apart
from viruses and bacteria, respiratory fungal infections are a major clinical issue, especially
in immunocompromised patients. Fungal pathogens like Cryptococcus, Aspergillus, and
Pneumocystis are known to cause severe lung infections mostly in immunodeficient
individuals such as HIV/AIDS patients, cancer chemotherapy receiving patients, and those
undergoing immunosuppressive treatment (109, 110). Respiratory pathogens grow and
replicate on respiratory epithelial cells and thus, it becomes immensely important to fully
understand the immunology of respiratory mucosal epithelial surfaces and corresponding
epithelial cells to better understand the respiratory disease progression and pathogenesis
(111, 112).
The expression and distribution of PRRs and other important biomolecules are found to be
similar between pigs and humans. The proximity between pigs and humans and similar
size and anatomy of major organs are vital in using pigs as an animal model and pig
respiratory cells in studying respiratory infections and immune responses in-vitro. The
selection of animal models depends on various factors like cost, anatomy,
proximity/similarity, feasibility, ethical reasons, and availability. Physiological and
anatomical similarity, easy availability, and feasibility contribute to choosing pigs as an
animal model. Using humans or human samples is an impractical and unethical way of
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conducting research and thus, animal models fill that void and are more practical and
ethical (89).
The use of pigs as an animal model for in-vitro immunological studies is not new and has
been ongoing for decades. Historically, most of the studies are conducted in intestinal
epithelial cells. Only a handful of studies have been carried out on respiratory cells to find
out their role in innate immune responses. More specifically, hardly any studies can be
found on the porcine respiratory epithelial cells and their contribution to the immune
system. Therefore, we hypothesized that both the pig primary and immortalized nasal
turbinate and tracheal epithelial cells established and characterized in this study express
epithelial markers and may serve as a good in-vitro models for studying the innate immune
responses to bacterial and viral ligands.
2.3 Materials and Methods
2.3.1

Culturing of established pig primary nasal turbinate and tracheal epithelial
cells

Using tissues collected from a day-old gnotobiotic piglet, primary nasal turbinate and
tracheal cell cultures were established in the previous study (113). Dulbecco’s Modified
Eagle Medium-F12 (DMEM/F-12) medium supplemented with 5 % fetal bovine serum
(FBS), 1% insulin-transferrin-selenium (ITS) (Invitrogen, Grand Island, NY), 5ng/ml
mouse epidermal growth factor (EGF) (Invitrogen, Grand Island, NY), and 1% antibiotics
(Penicillin-streptomycin) was used for culturing cells at 37◦ C, and 5 % CO2. Trypsin
(0.125% ) was used to remove any fibroblast contamination.
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2.3.2

Immunocytochemistry

Immunocytochemistry-based characterization of both the pig primary nasal turbinate
epithelial cells (PPNTECs) and pig primary tracheal epithelial cells

(PPTECs) and

respective immortalized cell lines was performed using monoclonal antibodies against cell
markers such as cytokeratin, vimentin, alpha-smooth muscle actin (ASMA), and desmin.
From 10^6 cells/ml cell suspension, 120ul of the cell suspension was used and cytospins
were made. Cytospins were air-dried for 1-2 hours and fixed in acetone for 7 mins. To
block endogenous peroxidase activity, slides were immersed in 1X PBS with 0.3%
hydrogen peroxide and 0.1% sodium azide. Slides were incubated in 1% goat serum for
about 20 mins to block the non-specific protein binding. The endogenous biotin activity
was blocked by using the avidin/biotin kit (Vector Laboratories). Cells were treated with
either the primary antibody or the isotype control antibody. Primary mouse monoclonal
antibodies at a concentration of 1µg/ml were made and cells were treated for 1 hour with
100µl of 1µg/ml antibody solutions specific against cytokeratin (mAb C6909; IgG2a
isotype), vimentin (mAb V5255; IgM isotype), alpha-smooth muscle actin (mAb A2457;
IgG2a isotype), or desmin (mAb D1033; IgG1 isotype) at room temperature. For isotype
control, M9144 (IgG2a isotype), M5170 (IgM isotype), and M9269 (IgG1 isotype)
antibodies were used. All these antibodies were obtained from Sigma-Aldrich. After an
hour, cells were washed with 1X PBS and incubated for 30 mins with isotype-specific
biotinylated goat-anti mouse IgG2a, IgM, or IgG1 antibodies (Caltag Laboratories) at
1:2000 dilutions. Cells were further incubated for 30 mins with streptavidin-horseradish
peroxidase (Vector Laboratories).

Ready-to-use (RTU) DAB (Diaminobenzidine)

substrate was added to the cells. Horseradish peroxidase cleaves this substrate and produces
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brown color indicating a positive reaction. Using hematoxylin, nuclear counterstaining was
done. Slides were dried overnight and mounted in mounting media, and images were taken
using a BX53 upright microscope.
2.3.3

SV40 immortalization of PPNTECs and PPTECs

To start with, half a million PPNTECs and PPTECs were separately cultured in four wells
of a 6-well plate using DMEM/F-12 culture media. After 18 hours of incubation, all four
wells were washed twice with sterile 1X PBS. To all four wells, 2 ml of serum-free OPTIMEM media (Gibco) was added. A microcentrifuge tube was labeled as tube 1 and 485ul
of OPTI-MEM along with 15ul of Lipofectamine (Invitrogen) was added and the tube was
incubated at room temperature for 10 minutes. To a second microcentrifuge tube labeled
as tube 2, 205 µl of Lipofectamine-OPTI-MEM mixture was transferred and 45 µl of pSV3neo (ATCC) plasmid vector with SV40 gene was added. After gently mixing the contents
in tube 2, it was incubated for 30 minutes at room temperature. To the first two wells
labeled as well 1 and well 2, 125ul of tube 1 contents without plasmid was added. To wells
3 and 4, 125 µl of the plasmid-lipofectamine mixture was added from tube 2. The 6 well
plates were then incubated at 37◦ C for 6 hours. After incubation, cells were washed with
1X PBS, and OPTI-MEM media was replaced by DMEM/F-12 media. Except for the first
well which is a positive control for normal cell growth, 40 µl of G418 antibiotic (Thermo
Fischer, Cat. no. 10131-035) was added to all labeled wells at a concentration of
1000ug/ml. After the antibiotic addition, the plate was incubated at 37◦ C for 24 hours and
colonies resistant to the antibiotic were observed under the microscope. Antibiotic-resistant
colonies from well 3 and 4 were trypsinized and transferred to a T-25 flask and cultured
and maintained in DMEM/F-12 media in presence of the selection antibiotic G418.

30

2.3.4

hTERT immortalization of PPTECs

Half-million PPTECs were cultured in the 3 wells of a 6-well plate and incubated for 18
hours at 37◦ C. After incubation, cells were washed with 1X PBS. Two Eppendorf tubes
were taken and labeled as tube 1 and tube 2. In tube 1, 15 µl of Lipofectamine reagent was
mixed with 485 µl of OPTI-MEM media. This mixture was then incubated for 15 minutes
at room temperature. In tube 2, 205 µl of the mixture from tube 1 was mixed with 45 µl of
100ng/µl pGRN-145 plasmid (ATCC) containing the hTERT gene. In the first and second
well, 125 µl of the non-plasmid mixture from tube 1 was added. In the third well, 125 µl
of the plasmid containing mixture from tube 2 was added. Cells were incubated for 6 hours
at 37◦ C and washed with 1x PBS. Cells in the second and third wells were again incubated
with 2 ml of DMEM/F12 medium containing Hygromycin B at a concentration of 100
µl/ml. Cells in the first well were used as a positive control for normal cell growth and only
DMEM/F12 medium was added without any selection antibiotics. After 14 days of
observation, antibiotic-resistant colonies were transferred to a T-25 flask and continued to
grow in DMEM/F12 medium as hTERT immortalized PPTECs.
2.3.5 Confirmation of immortalization
2.3.5.1 Polymerase chain reaction (PCR)
For SV40 immortalization, DNA was extracted from SV40 immortalized pig nasal
turbinate epithelial cells (PNTECs) and pig tracheal epithelial cells (PTECs) using DNeasy
Blood and Tissue Kit (Qiagen, cat. no.69504). A Nanodrop ND-1000 spectrophotometer
was used to measure the DNA concentration. Using specific primers for the SV40 gene
and Taq PCR Kit (New England Biolabs, cat. no. E5000S), PCR was performed (table 1).
The PCR cycle consisted of initial denaturation at 95◦ C for 5 minutes, followed by 30
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cycles of denaturation at 95◦ C for 30 seconds, annealing at 55◦ C for 1 minute, and
extension at 72◦ C for 1 minute. The final extension was done at 72◦ C for 10 minutes. PCR
products were resolved on 1.5 % agarose gel. Gel images were taken to further verify the
successful transfection.
For hTERT immortalization of PPTECs, using DNeasy Blood and Tissue Kit (Qiagen, cat.
no. 69504), DNA was isolated. Using specific primers for the hTERT gene (Table 1), PCR
was done. The following PCR conditions were used; initial denaturation at 95◦ C for 10
min, followed by 40 cycles of denaturation, annealing, and extension at 95◦ C for 30 sec,
60◦ C for 30 sec, 72◦ C for 60 sec, and final extension at 72◦ C for 60 sec. The products
obtained were resolved in an agarose gel and visualized using the ODYSSEY-FC gel
imaging system.
2.3.5.2 Immunocytochemistry for confirmation of hTERT protein expression
Cytospins were prepared using 1x105 cells. Using the earlier described IHC protocol (28),
immunocytochemical staining was conducted to confirm of expression of hTERT proteins.
Rabbit anti-TERT polyclonal IgG at a concentration of 1.25 µg/ml (Santa Cruz
Biotechnology Inc; SC 7212) was used for hTERT protein detection. Normal Rabbit IgG
(SC3888) was used for isotype-matched control. Slides were incubated with 100 µl of
either rabbit anti-TERT or normal rabbit IgG overnight at 4◦C. After incubation, slides were
washed three times with 1X PBS. After washing, 100 µl of biotinylated goat-anti-rabbit
IgG (1:1000 diluted) was added and incubated for 30 minutes followed by washing with
1X PBS three times. Slides were again incubated with the streptavidin-HRP solution for
30 minutes followed by the addition of DAB substrate for colorimetric detection of hTERT
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protein. Hematoxylin was used for nuclear counterstaining, and images were taken using
Olympus BX53 upright microscope.
Table 1: Primers used in the amplification of SV40 large T-antigen or hTERT gene
Primers

Product size

For SV40:
Forward:

706 BP

5’AGCAGACACTCTATGCCTGTGTGGAGTAAG3’
Reverse:
5’GACTTTGGAGGCTTCTGGATGCAACTGAG3’
For hTERT:
Forward:
5’-CGGAAGAGTGTCTGGAGCAA-3’
Reverse:

5’-GGATGAAGCGGAGTCTGGA-3’

125 BP
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2.3.5.3 Indirect

Immunofluorescence

assay

for

confirmation

of

SV40

immortalization
A 12 well-plate was used for the assay. In the first two wells labeled as well 1 and well 2,
50 thousand PPNTECs were added and in the next two wells labeled as well 3 and well 4,
50 thousand SV40 immortalized PNTECs were added. The 12 well-plate was incubated at
37◦ C for 24 hours. After 24 hours of incubation, cells were fixed with 1:1 acetone:
methanol (250ul/chamber) at -20◦ C for 10-15 minutes, washed three times with 1X PBS
and blocked with 1% goat serum for 20 minutes. 250µl (4µg/ml) of either mouse IgG2a
isotype control (M9144) or mouse anti-SV40 monoclonal IgG2a antibody was added to
respective wells and incubated at 37◦ C for 1 hour. All wells were treated with Alexa Fluor
488 conjugated goat anti-mouse IgG secondary antibody (Invitrogen, a11011) at 1:200
dilution and incubated for 1 hour in dark. Cells were washed with 1X PBS and nuclear
staining was performed using 250 µl of propidium iodide (1:1000 dilution) per well. After
5 minutes, cells were washed again and mounted in permafluor mounting medium, and
images were taken using Olympus BX53 upright microscope at 20X magnification. The
same procedure was repeated for indirect immunofluorescence assay of primary and SV40
immortalized tracheal epithelial cells.
2.3.6

Growth Kinetics study

Two 6-well plates were taken, one for culturing PPNTECs and another for culturing SV40immortalized PNTECs. To the 5 wells in each of the two 6-well plates, 20 thousand
PPNTECs and SV40 PNTECs were added respectively. The plates were incubated at 37 ◦
C for 48 hours. Beginning on day 2, the number of cells on each well of both 6-well plates
was counted until day 6. The same procedure was repeated two more times with both cell
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types. Population doubling time (DT) was calculated using the formula: DT=T
ln2/ln(X2/X1), where T is the incubation time in hours, X1 is the cell number at the
beginning of the incubation time and X2 is the cell number at the end of the incubation
time. The same procedure was repeated for the growth kinetics study of pig primary and
SV40 immortalized tracheal cells.
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2.4 Results
2.4.1

Phenotypic characterization of primary and SV40 immortalized pig primary
nasal turbinate and tracheal epithelial cells revealed typical epithelial
morphology/phenotype

Pig primary nasal turbinate and tracheal cells obtained from a day-old piglet (113) were
cultured in DMEM/F12 media. The initial cells used in this study were fibroblast
contaminated and thus, treated with 0.125% trypsin for 3 minutes to remove fibroblast
contamination, and obtain a homogenous population of cells. Cells showed typical
cobblestone morphology indicative of epithelial phenotype (Figure 5). Primary cells were
immortalized using the SV40 large T-antigen gene and hTERT gene. After a successful
transfection, cells were grown using similar culture conditions and they showed primary
cells like typical cobblestone morphology indicative of being epithelial (Figure 5-6).
However, cells did look more granulated after immortalization and started growing in
multiple small clusters.
Immunocytochemistry was performed to further verify the epithelial nature using
cytokeratin as universal epithelial cells marker. Primary and SV40 immortalized nasal
turbinate and tracheal epithelial cells strongly stained positive (>90%) for cytokeratin
(Figure 7-10). Less than 10% of the cells stained positive for vimentin which had been seen
across different epithelial cell lines in-vitro. Staining specificity was verified by negative
staining of isotype controls. Expression of desmin and alpha-smooth muscle actin were
virtually none on both primary and SV40 immortalized cells in both cell types.

36

2.4.2

SV40 immortalization of PPNTECs and PPTECs was confirmed by

conventional PCR and indirect immunofluorescence
DNA was extracted from both primary and SV40 immortalized cells. Using SV40 large Tantigen gene-specific primers, conventional PCR was performed, and the PCR products
were tested on an agarose gel to confirm the presence of SV40 large T-antigen gene on
SV40 immortalized cells. Gel image revealed the presence of SV40 large T-antigen gene
(Figure 11) with the product size around 706 bp.
An indirect Immunofluorescence assay (IFA) was done to further verify the SV40
immortalization based on SV40 protein expression. The assay used SV40 specific primary
antibody and Alexa fluor488 conjugated secondary antibody. SV40 immortalized cells
were strongly positive for SV40 protein expression. Primary cells along with isotype
controls were negative for SV40 protein expression (Figures 13 and 14). We were able to
successfully culture primary PPNTECs and PPTECs up to 16 passages. Immortalized
PPNTECs and PPTECs were grown up to 50 passages.
2.4.3

hTERT immortalization of PPTECs confirmed by conventional PCR and
immunocytochemistry

DNA was extracted from both primary and hTERT immortalized tracheal cells. Using
hTERT gene-specific primers, conventional PCR was performed, and the PCR products
were resolved on an agarose gel to confirm the presence of the hTERT gene on hTERT
immortalized cells. The gel image revealed the presence of the hTERT gene (Figure 11).
Immunocytochemistry (ICC) was done to further verify the hTERT immortalization based
on hTERT protein expression. hTERT immortalized cells were strongly positive for
hTERT protein expression. Primary cells stained slightly positive for hTERT protein.
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Isotype controls were negative for hTERT protein expression (Figure 12). hTERT
immortalized PPTECs were cultured up to passage number 16 successfully in DMEM/F12 culture media.
2.4.4

Growth kinetics showed a shorter mean doubling time for immortalized cells

Using the protocol described earlier, a growth kinetics study was conducted on both
primary and SV40 immortalized nasal turbinate epithelial cells and tracheal epithelial cells.
The mean doubling time was 27.47±0.26 hours for SV40 immortalized PPNTECs and
32.65±9.16 hours for primary PPNTECs. For primary tracheal epithelial cells, the mean
doubling time was 35.57±5.935 hours and for SV40 immortalized PPTECs, it was
28.99±3.575 hours. After immortalization, cells started to grow faster as shown by the
mean doubling time for the immortalized PPNTECs and PPTECs. Graphs were made
using GraphPad Prism software version 8.4.2 (Figure 15).
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Figure 5: Porcine primary and immortalized epithelial cells. A. Pig primary nasal turbinate
epithelial cells (PPNTECs). B. Pig primary tracheal epithelial cells (PPTECs). C. SV40
immortalized PPNTECs. D. SV40 immortalized PPTECs. Magnification 10x. Scale bars
represent 100 µM.
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Figure 6: Porcine primary and hTERT immortalized respiratory epithelial cells. A. Pig
primary tracheal epithelial cells (PPTECs). B. hTERT immortalized PPTECs.
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Figure 7: Immunocytochemistry-based characterization of porcine primary tracheal
epithelial cells. Cytokeratin staining produced strong brown color indicating DAB
substrate breakdown and positive staining (top left). Staining against vimentin, alphaSMA, desmin, and isotype controls produced negative results (staining did not produce
brown color) validating the epithelial nature of the cells. Magnification 10x, Scale bars
represent 100 µM.
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Figure 8: Immunocytochemistry-based characterization of porcine SV40 immortalized
tracheal epithelial cells. Cytokeratin staining produced strong brown color indicating DAB
substrate breakdown and positive staining (top left). Staining against vimentin, alphaSMA, desmin, and isotype controls produced negative results (staining did not produce
brown color) validating the epithelial nature of the cells. Magnification 10x, Scale bars
represent 100 µM.
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Figure 9: Immunocytochemistry-based characterization of porcine primary nasal turbinate
epithelial cells. Cytokeratin staining produced strong brown color indicating DAB
substrate breakdown and positive staining (top left). Staining against vimentin, alphaSMA, desmin, and isotype controls produced negative results (staining did not produce
brown color) validating the epithelial nature of the cells. Magnification 10x, Scale bars
represent 100 µM.
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Figure 10: Immunocytochemistry-based characterization of porcine SV40 immortalized
nasal turbinate epithelial cells. Cytokeratin staining produced strong brown color
indicating DAB substrate breakdown and positive staining (top left). Staining against
vimentin, alpha-SMA, desmin, and isotype controls produced negative results (staining did
not produce brown color) validating the epithelial nature of the cells. Magnification 10x,
Scale bars represent 100 µM.
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A. SV40 PPNTECs.

B. SV40 PPTECs

Lane 1: DNA ladder

Lane 1: DNA ladder

Lane 1: DNA ladder

Lane 2: SV40 plasmid

Lane 2: SV40 plasmid

Lane 2: pGRN145

Lane 3: SV40

Lane 3: SV40

plasmid

immortalized

immortalized PPTECs

Lane 3: hTERT

PPNTECs

Lane 4: PPTECs

immortalized PPTECs

Lane 4: PPNTECs

Lane 5: No template

Lane 4: PPTECs

Lane 5: No template

control

Lane 5: No template

control

C. hTERT PPTECs

control

Figure 11: Polymerase Chain Reaction (PCR) and agarose gel electrophoresis. A. Pig
primary and SV40 immortalized nasal turbinate epithelial cells. B. Pig primary and SV40
immortalized tracheal epithelial cells. C. Pig primary and hTERT immortalized tracheal
epithelial cells.
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Figure 12: Immunocytochemistry for confirmation of hTERT protein expression. A and B,
hTERT-PPTECs staining against hTERT specific antibody and isotype-matched control
respectively. C and D, Primary tracheal cells staining against hTERT specific antibody and
isotype-matched control respectively. Scale bar represents 100 µM, magnification 10X.
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Figure 13: IFA revealed expression of SV40 protein by SV40 immortalized nasal turbinate
epithelial cells. A & B: Pig primary and SV40 immortalized nasal turbinate epithelial cells
nuclear staining respectively. C & D: Pig primary and SV40 immortalized nasal turbinate
epithelial cells stained with SV40 specific primary Ab and Alexa 488 conjugated secondary
Ab. E & F: Merged pictures. Scale bar 50 µM.

47

Figure 14: IFA revealed expression of SV40 protein by SV40 immortalized tracheal
epithelial cells. A & B: Pig primary and SV40 immortalized tracheal epithelial cells nuclear
staining respectively. C & D: Pig primary and SV40 immortalized tracheal epithelial cells
stained with SV40 specific primary Ab and Alexa 488 conjugated secondary Ab. E & F:
Merged pictures. Scale bar 50 µM.
.
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A

B

Figure 11: A. Growth kinetics study of PPNTECs and SV40 immortalized PPNTECs. The
orange line represents the primary cells, and the blue line represents the SV40 immortalized
cells. 20,000 cells were cultured on day 0 and beginning on day 2, until day 6, cells were
counted using a hemocytometer. B. Growth kinetics study of PPTECs and SV40
Immortalized PPTECs. The orange line represents the primary cells, and the blue line
represents the SV40 immortalized cells. 20,000 cells were cultured on day 0 and beginning
on day 2, until day 6, cells were counted using a hemocytometer. The number of cells is in
thousands.
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2.5 Discussion
In this study, we have characterized pig primary respiratory epithelial cells from the trachea
and nasal turbinate and established SV40 and hTERT immortalized pig respiratory
epithelial cell lines. Primary cells have limited growth ability, and they tend to undergo
cell senescence after a certain age. Discovered by Hayflick almost 40 years ago, the
phenomenon where primary cells become senescent after a limited growth duration
because of a gradual loss of telomeric DNA after each cell division is known as Hayflick
Limit (99). Even though primary cells are indispensable tools in the immune system, an invitro study of the immune system might be jeopardized by primary cell senescence. Thus,
the establishment of immortalized cell lines becomes immensely important (114). In this
study, immortalized cell lines were generated using the SV40 and hTERT immortalization
methods. SV40 immortalization is based on the transfection of primary cells with the SV40
large T-antigen whereas the hTERT method uses pGRN145 plasmid for hTERT gene
transfection. Successful SV40 transfection leads to the expression of an oncoprotein and
thus, allows the cells to bypass replicative senescence (115). Both primary and
immortalized cells exhibited cobblestone morphology, a typical epithelial phenotypic
characteristic but, immortalized cells appeared more granulated and started growing in
multiple small clusters, unlike primary cells. It has been seen that the transfected cells can
display different structural and functional morphologies upon SV40 T-antigen transfection
(116). In a study conducted on human mammary epithelial cells, SV40 immortalization
resulted in frequent aneuploidy and chromosomal abnormalities (117). Even though we did
not study the changes at genomic levels, the granulated appearance of the immortalized
cells might be a result of genomic changes and subsequent expression of proteins
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responsible for the morphological appearance of the cells. Apart from that, both the primary
and immortalized cell lines expressed heavy cytokeratin, a universal epithelial cell marker
thus, confirming the epithelial nature of both cell types. After immortalization, cells were
able to grow faster possibly because primary cells require a close to the in-vivo
environment with complex culture conditions and different growth factors for their
sustained growth (118). However, immortalized cells require comparatively less
monitoring, and they tend to divide faster than primary cells in the same culture conditions.
Fibroblast contamination of the epithelial cell culture was a common problem in this study.
Pig respiratory cells from trachea and nasal turbinate isolated in a previous study (113)
were fibroblast contaminated (<10%). By exploiting the differences in adherence pattern
of the fibroblast cells and epithelial cells, fibroblast cells were removed from the epithelial
cell culture. Fibroblast cells are more sensitive to trypsin treatment because they loosely
adhere to the surface. Thus, cell culture flasks were treated with trypsin for 3 to 5 minutes
and all the detached cells were removed. This method seemed to be effective and has been
employed previously (113, 118, 119) but, needed to be repeated multiple times to get rid
of most of the fibroblast contamination.
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Chapter 3. Innate immune responses of porcine primary nasal turbinate and tracheal
epithelial cells upon stimulation with bacterial and viral ligands

3.1 Abstract
Respiratory epithelial cells express various pathogen recognition receptors (PRRs),
cytokines and chemokines, and play an important role in the innate immune responses
against respiratory pathogens. The primary objective of this study was to evaluate the
expression of various PRRs, cytokines and chemokines using RT-qPCR method in pig
primary nasal turbinate epithelial cells (PPNTECs) and pig primary tracheal epithelial cells
(PPTECs) in response to bacterial and viral ligands. The findings of this study indicated
that the porcine respiratory epithelial cells from both the nasal turbinate and trachea
constitutively expressed PRRs and various cytokines and chemokines, and expression of
specific PRRs, cytokine and chemokine genes were modulated upon stimulation with
bacterial and viral ligands. Therefore, the porcine respiratory epithelial cells from nasal
turbinate (PPNTECs) and trachea (PPTECs) may serve as a good model for studies
involving innate immune responses to pathogens and their mechanism for respiratory
disease pathogenesis. However, as we did not study the mechanistic details of our
observations at gene level, further studies are recommended to fully validate our findings.
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3.2 Introduction
The discovery of PRRs was a breakthrough for the field of immunology especially in
studying their role in the innate immune system. TLRs, RLRs, and NLRs are some of the
most studied PRRs and among them, TLRs were the first identified PRRs. TLRs initiate
host defense through their signaling pathways against foreign microbial particles (26). As
of now, mammals are known to express 13 different TLRs with different functions and
localization. Mostly, TLRs are expressed either on epithelial membranes or expressed
intracellularly. The expression of TLRs on mucosal epithelial surfaces is finely regulated
and this regulation is important for the controlled elicitation of innate immune responses
by antigen presenting cells (APCs) (29). NLRS and RLRs are involved in the activation
of NF-kB and MAPK signaling pathways followed by IFN-B production, a major cytokine
of the innate immune system. Additionally, IFN-B helps in the activation of B cells for
antibody production and thus, activation of adaptive immune response (66, 67). PRRs,
cytokines and chemokines genes and their expression are vital for generation of the innate
immune responses. Through various signaling pathways, PRRs, cytokines and chemokines
modulate the innate immune system and its response to pathogenic infections/invasions
(95).
Even though, respiratory epithelium is indispensable when it comes to innate immune
responses in porcine respiratory mucosa, very few studies have been conducted in porcine
respiratory epithelial cells. More importantly, there’s a lack of sufficient information on
porcine respiratory epithelial cells and their roles in respiratory immune responses and
respiratory diseases. To shed more light on roles of porcine respiratory cells on porcine
respiratory immune system and various porcine bacterial and viral respiratory diseases, in
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this study, we established and characterized primary and immortalized cultures of porcine
respiratory epithelial cells obtained from nasal turbinate and trachea of a day old
gnotobiotic piglet using various immunological and biochemical techniques and stimulated
them with bacterial and viral ligands to study their response towards the pathogenic ligand
stimulation. The primary and immortalized porcine respiratory cell cultures characterized
and stimulated with various bacterial and viral ligands may serve as a good model for
understanding the innate immune responses against respiratory pathogens and respiratory
diseases caused by them.
3.3 Materials and methods
For the ligand stimulation assay, various bacterial and viral ligands were used to stimulate
the PRRs, cytokines and chemokine genes in PPNTECs and PPTECs (Table 2). The
bacterial ligands included Lipopolysaccharide (LPS catalog: LG529) from Escherichia coli
O55: B55 at 5µg/ml concentration, peptidoglycan (PGN, catalog: tlrl-pgn) from
Staphylococcus aureus at 10µg/ml concentration, Flagellin (FLA, catalog: tlrl-stfla) from
Salmonella typhimurium at 100µg/ml concentration, Muramyl dipeptide (MDP, catalog:
tlrl-mdp) at 10µg/ml concentration and γ-D-glutamyl-meso-diaminopimelic acid (iE-DAP,
catalog: tlrl-dap). A TLR-4 agonist inulin acetate nanoparticle (InAc) synthesized from
plant polysaccharide inulin was also used in the ligand stimulation assay (120). For the
viral ligand study, viral nucleoside analogs; imiquimod (catalog: tlrl-imqs) at 5µg/ml
concentration, polyinosonic: polycytidylic acid (Poly I:C, catalog: tlrl-pic) at 5µg/ml, and
poly I:C with lyovec (Poly I:C/lyovec, catalog: tlrl-piclv) at 1µg/ml concentration were
used to stimulate various PRRs. These ligands were obtained from InvivoGen (San Diego,
USA).
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Table 2: Ligands used in the stimulation of PPNTECs and PPTECs.
Ligands

name of receptors

Source

Concentration

Lipopolysaccharide

Surface; TLR4

Escherichia coli

5 µg/ml

O55: B55
Peptidoglycan

Surface; TLR2

Staphylococcus

10 µg/ml

aureus
Flagellin

Surface; TLR5

100 µg/ml

Salmonella
typhimurium

Muramyl dipeptide

Cytoplasm; NOD2

Mycobacteria

γ-D-glutamyl-meso-

Cytoplasm; NOD1

Gram-positive and 10 µg/ml

diaminopimelic acid

10 µg/ml

gram-negative
bacteria

Inulin acetate

Surface; TLR4

A

plant

product 250 µg/ml

inulin

Poly I:C

Endosomes; TLR3

Synthetic analogue 5 µg/ml
of double stranded
RNA
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Poly I:C with lyovec

Cytoplasm; RIG-I

Poly

I:C

with 1 µg/ml

transfecting reagent
lyovec
Imiquimod

3.3.1

Endosomes;

Synthetic nucleotide 5 µg/ml

TLR7/8

analogue

RNA extraction and cDNA preparation

Cells were grown on a 6-well plate until 80% confluent, washed with 1X PBS, stimulated
with bacterial and viral ligands for 3 and 24 hours, and trypsinized using 0.125% trypsin
EDTA. The harvested cells were pelleted by centrifugation at 1200 rpm for 5 minutes.
Following the RNeasy Mini Kit (Qiagen, catalog: 74101) protocol, RNA was extracted.
Extracted RNA was quantified using a Nanodrop 2000 and stored at -80◦ C. For cDNA
preparation, 1 ug RNA was reverse transcribed using a TaqMan reverse transcriptase kit
(Applied Biosystems, catalog: N8080234) following the manufacturer’s protocol. The
resulting cDNA was diluted 5 times for further application. Each experiment was repeated
3 times.
3.3.2

Real-Time quantitative PCR (RT-qPCR)

In an Eppendorf tube, the master mix was made using 5 µl of SYBR green master mix (RT2
SYBR Green ROX, catalog: 330523. Qiagen Sciences, Maryland, USA), 0.5 µl of forward
and reverse primers, and 3 µl of nuclease-free water. 9 µl of master mix and 1 µl of diluted
cDNA were mixed to make a final volume of 10µl and the RT-qPCR reaction was carried
out on a 96-well PCR plate using QuantstudioTM Flex Real-Time PCR System (Applied
Biosystems, NJ, USA). Gene expression analysis of various TLRs, RLRs, NLRs, and

56

cytokines/chemokines were studied using the specific primers (Table 3) Cyclophilin-A
gene was used as a housekeeping gene. All the primers used in this study were designed in
previous studies (121-123).
Table 3: List of genes and respective primers used in the stimulation assay.
Gene

Primer sequence (5’-3’)

Accession

Annealing

number

Tempera-

Reference

ture (◦ C)

TLR1

F: TGCTGGATGCTAACGGATGTC

AB219664

55

(124)

AB085935

55

(124)

DQ266435

55

(124)

AB188301

55

(124)

NM_001123202

55

(125)

AB085936

55

(124)

R: AAGTGGTTTCAATGTTGTTC

AAAGTC

TLR-2

F: TCACTTGTCTAACTTATCATC

CTCTTG

R: TCAGCGAAGGTGTCATTATTGC

TLR-3

F: AGTAAATGAATCACCCTGCC

TAGCA

R: GCCGTTGACAAAACACATA

AGGACT

TLR-4

F: GCCATCGCTGCTAACATCATC

R: CTCATACTCAAAGATACACC

ATCGG

TLR-5

F: CCTTCCTGCTTCTTTGATGG

R: CTGTGACCGTCCTGATGTAG

TLR-6

F: AACCTACTGTCATAAGCCTTC

57
ATTC

R: GTCTACCACAAATTCACTTTC

TTCAG

TLR-7

F: ACAATGATATCGCCACCTCC

NM_001097434

55

(126)

AY859728

57

(124)

NM_001114277

55

(127)

NM_001105295

55

(127)

NM_213804

60

(128)

XM_003362075

55

(129)

ACCA

R: TGCCCAAGGAGAGAGTCTT

CAGAT

TLR-9

F: CACGACAGCCGAATAGCAC

R: GGGAACAGGGAGCAGAGC

NOD-1

F: CTGTCGTCAACACCGATCCA

R: CCAGTTGGTGACGCAGCTT

NOD-2

F: GAGCGCATCCTCTTAACTTTCG

R: ACGCTCGTGATCCGTGAAC

RIG-I

F: TATCCGAGCCGCAGGCTTTG

ATGA

R: AGTTTAGGGTTCTCGTTGTTG

CTGGGA

Beta

F: TGCCACAGGTGCCGATCT

defensins11

R: CTGTTAGCTGCTTAAGGAATA

AAG GC

58
Beta

F: CCAGAGGTCAAACCACTACA

defensins2

R: GGTCCCTTCAATCCTGTTGAA

MDA-5

F: TGCCCTTTCCCAGTGGATTA

NM_214442

55

(129)

NM_001100194

60

(128)

M86725

57

(127)

NM_86722

60

(127)

AB035380

57

(127)

L20001

55

(124)

L35765

60

(127)

NM_214214

60

(127)

X57191

60

(127)

CTGA

R: TGTGTCCAGCTCCAATCAG

ATTTG

IL-1a

F: AGAATCTCAGAAACCCGAC

TGTTT

R: TTCAGCAACACGGGTTCGT

IL-1b

F: GCCCTGTACCCCAACTGGTA

R: CCAGGAAGACGGGCTTTTG

IL-6

F: TGGATAAGCTGCAGTCACAG

R: ATTATCCGAATGGCCCTCAG

IL-8

F: TTCGATGCCAGTGCATAAATA

R: CTGTACAACCTTCTGCACCCA

IL-10

F: TGGGTTGCCAAGCCTTGT

R: GCCTTCGGCATTACGTCTTC

TNF-a

F: CGACTCAGTGCCGAGATCAA

R: CCTGCCCAGATTCAGCAAAG

IFN-a

F: CCCCTGTGCCTGGGAGAT

R: AGGTTTCTGGAGGAAGA

59
GAAGG

IFN-b

F: AGTTGCCTGGGACTCCTCAA

M86762

60

(127)

55

NM_001077213

(127)

NM_214353.1

55

(127)

R: CCTCAGGGACCTCAA

AGTTCAT

MCP-1

F: ACCAGCAGCAAGTGTCC

TAAAG

R: GTCAGGCTTCAAGGCTTCGG

CYCLO-a

F: CCTGAACATACGGGTCCTG

R: AACTGGGAACCGTTTGTGTTG
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3.3.3

Statistical analysis

Experiments were conducted 3 times for reproducibility. Cyclophilin-A was used as an
internal control to normalize cycle threshold (Ct) obtained from RT-qPCR reaction for
various PRRs genes. mRNA fold change was calculated using the following formula: 2ΔΔCt

= 2- (CT value of target gene of the treatment-CT value of housekeeping gene of treatment)- (CT value of the negative control-

CT value of housekeeping gene of the negative control)

. A two-tailed student’s t-test was used to analyze the

average fold change of three repeats. P values < 0.05 were considered significant for the
study. Graphing was accomplished using GraphPad Prism software version 8.4.
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3.4 Results
3.4.1

Changes in gene expression following bacterial ligand stimulation of pig
primary nasal turbinate epithelial cells

Using specific primers, changes in gene expression of 8 different TLRs in response to
various bacterial ligands were examined. Expression of various RLRs and NLRs, and
defensins were also tested along with different cytokines/chemokines. Real-time reverse
transcription (RT-qPCR) was performed, and Cyclophilin-A was used as a housekeeping
gene.
Twenty-four hours of LPS stimulation significantly increased the expression of TLR-1.
TLR-2, TLR-5, and TLR-6 expression increased both at 3 hours and 24 hours of LPS
stimulation, but the changes were statistically non-significant. In contrast, 3 hours of LPS
stimulation caused a decrease in TLR-7 and TLR-9 expression, but the changes were nonsignificant (Figure 16). Three hours of LPS stimulation significantly increased the
expression of Beta-defensins 2. LPS stimulation for 24 hours caused a huge spike in RIGI gene expression. However, high variation rendered the spike statistically non-significant.
LPS stimulation had little effect on MDA-5, NOD-1, NOD-2, and Beta-defensins 1 gene
expression as the changes were statistically non-significant (Figure 21). LPS significantly
increased IL-10 expression after 24 hours and significantly increased TNF-alpha
expression at 3 hours. MCP-1 gene expression decreased after 3 hours of LPS stimulation
significantly. LPS stimulation had little effect on other cytokines/chemokines (Figure 26).
There were no significant changes in TLRs, RLRs, NLRs, and defensins gene expression
upon PGN stimulation at both 3 hours and 24 hours’ time point (Figure 17 and 22). Except
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for significantly decreased expression of MCP-1 gene after 3 hours, PGN did not induce
further significant changes in the rest of the cytokine and chemokine genes ( Figure 27).
FLA caused TLR-2 and IL-1b gene expression to spike after 3 hours of stimulation with
statistical significance. Apart from that, FLA did not induce further significant changes in
gene expression for any other PRRs, cytokines and chemokines (Figure 18, 23 and 28).
Out of all the PRRs, cytokines and chemokines tested, MDP only caused a significant
decrease in the expression of IFN-beta gene after 24 hours of stimulation (Figure 19, 24
and 29). In addition to a significant decrease in NOD-2 gene expression after 24 hours, iEdap caused IL-6 gene expression to change significantly both after 3 and 24 hours of
stimulation (Figure 20, 25 and 30).
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3.4.2

Changes in gene expression following viral ligand stimulation of pig primary
nasal turbinate epithelial cells

There was a significant increase in TLR-6 expression after 3 hours of Poly I:C stimulation.
However, Poly I:C stimulation did not induce any further significant changes in the rest of
the PRRs, cytokines and chemokines (Figure 31, 35, and 39). Poly I:C with lyovec (Figure
32, 36 and 40) and imiquimod (Figure 34, 38 and 42) treatment were ineffective in
producing any changes in any of the PRRs, cytokines and chemokines gene expression.
Along with the viral ligands, a TLR-4 agonist inulin acetate nanoparticles were used to
stimulate the cells. Inulin acetate significantly (Figure 33) downregulated the gene
expression by causing TLR-1, TLR-2, and TLR-5 genes to decrease in their expression
significantly after 24 hours of stimulation. Similarly, inulin acetate after 24 hours, caused
a significant decrease in the expression of MDA-5, RIG-I, NOD-2, and Beta-defensin 2
genes (Figure 37). Inulin acetate also caused the significant downregulation of IL-10 and
IFN-alpha after 24 hours of stimulation (Figure 41). Thus, inulin acetate affected specific
PRRs, cytokines and chemokines, and caused their significant downregulation.
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Figure 12: Various TLRs and their changes in gene expression based on LPS stimulation
in PPNTECs. Bar graphs are the mean of three independent experiments and error bars
represent the standard error of mean (SEM). Using delta-delta Ct method, fold change was
calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 13: Various TLRs and their changes in gene expression based on PGN stimulation
in PPNTECs. Bar graphs are the mean of three independent experiments and error bars
represent the standard error of mean (SEM). Using delta-delta Ct method, fold change was
calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 14: Various TLRs and their changes in gene expression based on FLA stimulation
in PPNTECs. Bar graphs are the mean of three independent experiments and error bars
represent the standard error of mean (SEM). Using delta-delta Ct method, fold change was
calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 15: Various TLRs and their changes in gene expression based on MDP stimulation
in PPNTECs. Bar graphs are the mean of three independent experiments and error bars
represent the standard error of mean (SEM). Using delta-delta Ct method, fold change was
calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 16: Various TLRs and their changes in gene expression based on iE-dap stimulation
in PPNTECs. Bar graphs are the mean of three independent experiments and error bars
represent the standard error of mean (SEM). Using delta-delta Ct method, fold change was
calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 17: RLRs, NLRs and other PRRs, and their changes in gene expression based on
LPS stimulation in PPNTECs. Bar graphs are the mean of three independent experiments
and error bars represent the standard error of mean (SEM). Using delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 18: RLRs, NLRs and other PRRs, and their changes in gene expression based on
PGN stimulation in PPNTECs. Bar graphs are the mean of three independent experiments
and error bars represent the standard error of mean (SEM). Using delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 19: RLRs, NLRs and other PRRs, and their changes in gene expression based on
FLA stimulation in PPNTECs. Bar graphs are the mean of three independent experiments
and error bars represent the standard error of mean (SEM). Using delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 20: RLRs, NLRs and other PRRs, and their changes in gene expression based on
MDP stimulation in PPNTECs. Bar graphs are the mean of three independent experiments
and error bars represent the standard error of mean (SEM). Using delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 21: RLRs, NLRs and other PRRs, and their changes in gene expression based on
iE-dap stimulation in PPNTECs. Bar graphs are the mean of three independent experiments
and error bars represent the standard error of mean (SEM). Using delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 22: Cytokines/chemokines, and their changes in gene expression based on LPS
stimulation in PPNTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of mean (SEM). Using delta-delta Ct method, fold
change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 23: Cytokines/chemokines, and their changes in gene expression based on PGN
stimulation in PPNTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of mean (SEM). Using delta-delta Ct method, fold
change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 24: Cytokines/chemokines, and their changes in gene expression based on FLA
stimulation in PPNTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of mean (SEM). Using delta-delta Ct method, fold
change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 25: Cytokines/chemokines, and their changes in gene expression based on MDP
stimulation in PPNTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of mean (SEM). Using delta-delta Ct method, fold
change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 26: Cytokines/chemokines, and their changes in gene expression based on iE-dap
stimulation in PPNTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of mean (SEM). Using delta-delta Ct method, fold
change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 27: Various TLRs and their changes in gene expression based on Poly I:C
stimulation in PPNTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of mean (SEM). Using delta-delta Ct method, fold
change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 28: Various TLRs and their changes in gene expression based on Poly I:C with
lyovec stimulation in PPNTECs. Bar graphs are the mean of three independent experiments
and error bars represent the standard error of mean (SEM). Using delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 29: Various TLRs and their changes in gene expression based on Inulin acetate
stimulation in PPNTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of mean (SEM). Using delta-delta Ct method, fold
change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 30: Various TLRs and their changes in gene expression based on imiquimod
stimulation in PPNTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of mean (SEM). Using delta-delta Ct method, fold
change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 31: RLRs, NLRs, and other PRRs, and their changes in gene expression based on
Poly I:C stimulation in PPNTECs. Bar graphs are the mean of three independent
experiments and error bars represent the standard error of mean (SEM). Using delta-delta
Ct method, fold change was calculated. Significant changes are represented by an asterisk
(*), p<0.05.
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Figure 32: RLRs, NLRs, and other PRRs, and their changes in gene expression based on
Poly I:C with lyovec stimulation in PPNTECs. Bar graphs are the mean of three
independent experiments and error bars represent the standard error of mean (SEM). Using
delta-delta Ct method, fold change was calculated. Significant changes are represented by
an asterisk (*), p<0.05.
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Figure 33: RLRs, NLRs, and other PRRs, and their changes in gene expression based on
Inulin acetate stimulation in PPNTECs. Bar graphs are the mean of three independent
experiments and error bars represent the standard error of mean (SEM). Using delta-delta
Ct method, fold change was calculated. Significant changes are represented by an asterisk
(*), p<0.05.
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Figure 34: RLRs, NLRs, and other PRRs, and their changes in gene expression based on
imiquimod stimulation in PPNTECs. Bar graphs are the mean of three independent
experiments and error bars represent the standard error of mean (SEM). Using delta-delta
Ct method, fold change was calculated. Significant changes are represented by an asterisk
(*), p<0.05.
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Figure 35: Cytokines/chemokines, and their changes in gene expression based on Poly I:C
stimulation in PPNTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of mean (SEM). Using delta-delta Ct method, fold
change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 36: Cytokines/chemokines, and their changes in gene expression based on Poly I:C
with lyovec stimulation in PPNTECs. Bar graphs are the mean of three independent
experiments and error bars represent the standard error of mean (SEM). Using delta-delta
Ct method, fold change was calculated. Significant changes are represented by an asterisk
(*), p<0.05.
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Figure 37: Cytokines/chemokines, and their changes in gene expression based on Inulin
acetate stimulation in PPNTECs. Bar graphs are the mean of three independent experiments
and error bars represent the standard error of mean (SEM). Using delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 38: Cytokines/chemokines, and their changes in gene expression based on
imiquimod stimulation in PPNTECs. Bar graphs are the mean of three independent
experiments and error bars represent the standard error of mean (SEM). Using delta-delta
Ct method, fold change was calculated. Significant changes are represented by an asterisk
(*), p<0.05.
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3.4.3

Changes in gene expression following bacterial ligand stimulation of pig

primary tracheal epithelial cells
Except for upregulation of TLR-2 gene expression upon iE-dap stimulation for 24 hours,
there were not any significant changes in gene expression of different TLRs upon bacterial
ligand stimulation (Figure 43-47). While gene expression of RIG-I and NOD-1 upregulated
significantly upon LPS stimulation for 3 hours (Figure 48), LPS downregulated IL-10
expression significantly after 24 hours of stimulation (Figure 53). PGN stimulation did not
induce any significant changes in PRRs, cytokine and chemokine gene expression ( Figure
44, 49 and 54).
NOD-2 gene expression decreased significantly after 3 hours of FLA stimulation. FLA
caused RIG-I expression after 3 hours of stimulation to spike, but the change was not found
to be statistically significant (Figure 50). MDP stimulation did not induce any changes in
the expression of PRRs, cytokine and chemokine genes ( Figure 46, 51 and 56). A
significant increase in IL-6 and IL-1α gene expression was found after 3 hours and 24 hours
of iE-dap stimulation respectively (Figure 57).
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3.4.4 Changes in gene expression following viral ligand stimulation of pig primary
tracheal epithelial cells
Only TNF-alpha showed a significant increase in gene expression upon Poly I:C
stimulation after 24 hours. Expression of IFN-b skyrocketed after 24 hours of Poly I:C
stimulation, but the change was found to be non-significant. Apart from that, Poly I:C
stimulation did not induce any further statistically significant changes in gene expression
of various PRRs, cytokine and chemokine genes (Figure 58, 62, 66).
Poly I:C with lyovec stimulation significantly decreased TLR-4 and TLR-5 gene
expression after 3 hours (Figure 59). Significant downregulation of NOD-1 gene was
observed after 3 and 24 hours of Poly I:C with lyovec stimulation. Consistent with NOD1, Poly I:C with lyovec stimulation caused NOD-2 gene expression to go down
significantly after 3 hours. MDA-5 gene expression increased significantly after 24 hours
of Poly I:C with lyovec stimulation (Figure 63). IL-1B, IL-10, and IFN-A gene decreased
significantly in their expression after 3 hours of Poly I:C with lyovec stimulation.
Expression levels of TNF-A gene went up significantly after 24 hours of Poly I:C with
lyovec stimulation (Figure 67). Both inulin acetate and imiquimod stimulation did not
change the expression of PRRs ( Figure 60, 61, 64 and 65); however, inulin acetate
stimulation induced significant changes in beta defensin-1 and TNF-α gene expression (
Figure 64 and 68).
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Figure 39: Various TLRs and their changes in gene expression based on LPS stimulation
in PPTECs. Bar graphs are the mean of three independent experiments and error bars
represent the standard error of the mean (SEM). Using the delta-delta Ct method, fold
change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 40: Various TLRs and their changes in gene expression based on PGN stimulation
in PPTECs. Bar graphs are the mean of three independent experiments and error bars
represent the standard error of the mean (SEM). Using the delta-delta Ct method, fold
change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 41: Various TLRs and their changes in gene expression based on FLA stimulation
in PPTECs. Bar graphs are the mean of three independent experiments and error bars
represent the standard error of the mean (SEM). Using the delta-delta Ct method, fold
change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 42: Various TLRs and their changes in gene expression based on MDP stimulation
in PPTECs. Bar graphs are the mean of three independent experiments and error bars
represent the standard error of the mean (SEM). Using the delta-delta Ct method, fold
change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 43: Various TLRs and their changes in gene expression based on iE-dap stimulation
in PPTECs. Bar graphs are the mean of three independent experiments and error bars
represent the standard error of the mean (SEM). Using the delta-delta Ct method, fold
change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 44: RLRs, NLRs, and other PRRs, and their changes in gene expression based on
LPS stimulation in PPTECs. Bar graphs are the mean of three independent experiments
and error bars represent the standard error of mean (SEM). Using delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 45: RLRs, NLRs, and other PRRs, and their changes in gene expression based on
PGN stimulation in PPTECs. Bar graphs are the mean of three independent experiments
and error bars represent the standard error of mean (SEM). Using delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 46: RLRs, NLRs, and other PRRs, and their changes in gene expression based on
FLA stimulation in PPTECs. Bar graphs are the mean of three independent experiments
and error bars represent the standard error of mean (SEM). Using delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 47: RLRs, NLRs, and other PRRs, and their changes in gene expression based on
MDP stimulation in PPTECs. Bar graphs are the mean of three independent experiments
and error bars represent the standard error of mean (SEM). Using delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 48: RLRs, NLRs, and other PRRs, and their changes in gene expression based on
iE-dap stimulation in PPTECs. Bar graphs are the mean of three independent experiments
and error bars represent the standard error of mean (SEM). Using delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 49: Cytokines/chemokines, and their changes in gene expression based on LPS
stimulation in PPTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of the mean (SEM). Using the delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 50: Cytokines/chemokines, and their changes in gene expression based on PGN
stimulation in PPTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of the mean (SEM). Using the delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 51: Cytokines/chemokines, and their changes in gene expression based on FLA
stimulation in PPTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of the mean (SEM). Using the delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 52: Cytokines/chemokines, and their changes in gene expression based on MDP
stimulation in PPTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of the mean (SEM). Using the delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 53: Cytokines/chemokines, and their changes in gene expression based on iE-dap
stimulation in PPTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of the mean (SEM). Using the delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 54: Various TLRs and their changes in gene expression based on Poly I:C
stimulation in PPTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of the mean (SEM). Using the delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 55: Various TLRs and their changes in gene expression based on Poly I:C with
lyovec stimulation in PPTECs. Bar graphs are the mean of three independent experiments
and error bars represent the standard error of the mean (SEM). Using the delta-delta Ct
method, fold change was calculated. Significant changes are represented by an asterisk (*),
p<0.05.
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Figure 56: Various TLRs and their changes in gene expression based on Inulin acetate
stimulation in PPTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of the mean (SEM). Using the delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 57: Various TLRs and their changes in gene expression based on imiquimod
stimulation in PPTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of the mean (SEM). Using the delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 58: RLRs, NLRs, and other PRRs, and their changes in gene expression based on
Poly I:C stimulation in PPTECs. Bar graphs are the mean of three independent experiments
and error bars represent the standard error of mean (SEM). Using delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 59: RLRs, NLRs, and other PRRs, and their changes in gene expression based on
Poly I:C with lyovec stimulation in PPTECs. Bar graphs are the mean of three independent
experiments and error bars represent the standard error of mean (SEM). Using delta-delta
Ct method, fold change was calculated. Significant changes are represented by an asterisk
(*), p<0.05.
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Figure 60: RLRs, NLRs, and other PRRs, and their changes in gene expression based on
Inulin acetate nanoparticle stimulation in PPTECs. Bar graphs are the mean of three
independent experiments and error bars represent the standard error of mean (SEM). Using
delta-delta Ct method, fold change was calculated. Significant changes are represented by
an asterisk (*), p<0.05.
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Figure 61: RLRs, NLRs, and other PRRs, and their changes in gene expression based on
Imiquimod stimulation in PPTECs. Bar graphs are the mean of three independent
experiments and error bars represent the standard error of mean (SEM). Using delta-delta
Ct method, fold change was calculated. Significant changes are represented by an asterisk
(*), p<0.05.

116

Figure 62: Cytokines/chemokines, and their changes in gene expression based on Poly I:C
stimulation in PPTECs. Bar graphs are the mean of three independent experiments and
error bars represent the standard error of the mean (SEM). Using the delta-delta Ct method,
fold change was calculated. Significant changes are represented by an asterisk (*), p<0.05.
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Figure 63: Cytokines/chemokines, and their changes in gene expression based on Poly I:C
with lyovec stimulation in PPTECs. Bar graphs are the mean of three independent
experiments and error bars represent the standard error of the mean (SEM). Using the deltadelta Ct method, fold change was calculated. Significant changes are represented by an
asterisk (*), p<0.05.
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Figure 64: Cytokines/chemokines, and their changes in gene expression based on Inulin
acetate nanoparticle stimulation in PPTECs. Bar graphs are the mean of three independent
experiments and error bars represent the standard error of the mean (SEM). Using the deltadelta Ct method, fold change was calculated. Significant changes are represented by an
asterisk (*), p<0.05.
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Figure 65: Cytokines/chemokines, and their changes in gene expression based on
imiquimod stimulation in PPTECs. Bar graphs are the mean of three independent
experiments and error bars represent the standard error of the mean (SEM). Using the deltadelta Ct method, fold change was calculated. Significant changes are represented by an
asterisk (*), p<0.05.
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3.5 Discussion
In this study, pig primary respiratory epithelial cells from the trachea (PPTECs) and nasal
turbinate (PPNTECs) were stimulated with various bacterial and viral ligands to
explore/identify whether these cells modulate the expression of various pathogen
recognition receptors, cytokines and chemokines genes and if they do what roles these cells
play in the innate immune responses associated with bacteria or viral pathogenic
determinants. Primary cells from both trachea and nasal turbinate were stimulated with
bacterial ligands LPS, PGN, FLA, MDP, and i.E.-DAP and, viral ligands Poly I:C, Poly
I:C with lyovec, and imiquimod. In addition, inulin acetate nanoparticles, known to be
agonist of TLR4, were also used to stimulate these cells.
RT-qPCR data analysis revealed that both PPTECs and PPNTECs express various TLRs,
NLRS, RLRs, defensins, cytokines and chemokine genes constitutively. The very fact that
these cells express various PRRs, cytokines and chemokines genes render them relevant
and effective in studying respiratory disease pathogenesis and the innate immune system.
LPS, an outer surface membrane component of almost all gram-negative bacteria, has an
immunostimulatory lipid A component that acts as a strong innate immunity stimulator.
The extracellular involvement of LPS binding protein (LBP), CD14, and TLR4/MD-2
complex results in LPS recognition leading to the activation of MyD88 or TRIF pathways
(130).
In the stimulation assay conducted with PPNTECs, LPS caused upregulation of TNF-A
and MCP-1-proinflammatory cytokines/chemokines, at 3 hours’ time point. Previous
studies have shown that TNF- alpha and MCP-1 production is triggered or upregulated
upon LPS stimulation (131, 132). Apart from B-defensin 2 and TLR-1 upregulation after
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3 and 24 hours of stimulation respectively, LPS did not induce any changes in the gene
expression of other TLRs including TLR-4. To our knowledge, this is the first ligand
stimulation assay conducted on pig respiratory epithelial cells, but our findings are
consistent with studies conducted on IPEC-J2 cell lines (132, 133). IL-10 is an antiinflammatory and immunosuppressive cytokine and is highly regulated at the transcription
level. LPS stimulation of PPNTECs caused the significant upregulation of IL-10 gene
expression. Consistent with this, in another study, LPS is known to cause the increased IL10 gene expression (134). Activation of MyD88 or TRIF signaling pathway after LPSTLR4/MD-2 binding causes the production of proinflammatory cytokines. To contain the
inflammation, anti-inflammatory cytokines are released into the system, and this creates a
balance between pro-inflammatory and anti-inflammatory cytokines (85). An imbalance
between pro-inflammatory and anti-inflammatory cytokines is attributed to bipolar
disorder (135).
In the stimulation assay conducted with PPTECs, LPS caused significant upregulation of
RIG-I and NOD-1 genes. NOD-1 upregulation might be because LPS is a PAMP or a
danger signal, and NOD-1 serves to identify the presence of danger signals to restore
homeostasis. Encounter with a danger signal results in the activation of NOD-1 signaling
cascades (136). Unlike in PPNTECs, LPS caused significant downregulation of IL-10 in
PPTECs after 3 hours of stimulation. A possible explanation might be that IL-10 expression
is highly regulated and only proceeds when there are hyper levels of pro-inflammatory
cytokines. However, in this study based on gene expression levels, none of the proinflammatory cytokines were significantly upregulated upon LPS stimulation in PPTECs.
Most of the gene expression patterns in response to LPS were similar between PPNTECs

122

and PPTECs except for a few differences. The differences might be a result of their
different anatomical location, physiological properties, and variation in the receptors they
express.

PGN is a major cell wall component derived from a Gram-positive bacterium. PGN is
known to activate TLR-2 and NOD-2. While TLR-2 binds to PGN, NOD-2 binds to MDP,
a PGN breakdown component thus can also detect PGN (137). Even though both TLR-2
and NOD-2 sense PGN, no or very few significant changes in mRNA gene expression for
various PRRs were observed upon PGN stimulation. Having said that, in PPTECs, after 24
hours of PGN stimulation, both TLR-2 and NOD-2 gene expression levels were
upregulated. Even in PPNTECs, 24 hours of PGN stimulation yielded higher expression of
NOD-2 compared to 3 hours. The insignificant but increased expression after 24 hours of
stimulation may be a result of the insufficient PGN dose used or inadequate time for PGN
to produce significant effects. A higher dose and a longer stimulation time may produce
better results. Another possible reason could be the use of the purified version of PGN in
our study as it has been observed that the purification process renders PGN to become less
effective (137).
MCP-1 is a chemokine involved in the migration of monocytes and lymphocytes in case
of an injury or an infection and helps in promoting inflammation. It also regulates
monocyte differentiation into dendritic cells (138). In this study, the PGN significantly
downregulated MCP-1 expression after 3 hours of stimulation in PPNTECs. In a study
conducted on microglial cells of mice, PGN successfully downregulated the expression of
MCP-1 along with TLR-2 and TNF-alpha expression upregulated by LPS challenge (139).
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While this study was conducted on already induced microglial cells, the fact that PGN
downregulated MCP-1 expression is consistent with our observation. PGN produced little
to no effect on other cytokines and chemokines genes.
FLA is a structural component of bacterial flagella that binds to TLR-5 and activates NFkB signaling which results in the generation of innate immune responses through
proinflammatory gene expression against flagellated bacterium (140, 141). FLA
stimulation of PPNTECs resulted in increased expression of IL-1b. As stated above, IL-1b
is a proinflammatory cytokine and FLA/TLR5 downstream signaling induces increased
expression of proinflammatory cytokines. PPNTECs constitutively expressed TLR-5 but
FLA did not upregulate TLR-5 gene expression. It suggests that the high levels of IL-1b
are a result of FLA/TLR-5 binding and activation of downstream signaling.
In PPNTECs, FLA caused significant upregulation of TLR-2 after 3 hours of stimulation.
Previous studies have shown that gastric epithelial cells make use of TLR-2 and TLR-5 to
respond against Helicobacter pylori, a Gram-negative, flagellated bacterial infection (142).
Even though the cells used in this study are from the respiratory tract of pigs, the correlation
between TLR-2 and flagellated bacterial infection might be a factor behind elevated levels
of TLR-2 gene expression upon FLA stimulation. On the contrary, a study conducted on
human airway epithelial cells infection via flagellin of Pseudomonas aeruginosa
demonstrated that TLR-2 dependent immune responses are flagellin independent. Another
study conducted with Haemophilus influenzae, a flagellum-free bacteria, demonstrated that
lack of flagella did not induce TLR-5 but significantly stimulated TLR-2 citing TLR-5, not
TLR-2, as a receptor for flagellin (143).
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In PPTECs, FLA induced significant NOD-2 downregulation after 3 hours of stimulation.
There’s no direct link between FLA stimulation and NOD-2 downregulation. NODs are
cytosolic receptors important in recognizing intracellular ligands. NODs are shown to be
involved in binding with flagellin and activation of the NF-kB pathway (144, 145). RIG-I
levels were spiked upon 3 hours of FLA stimulation, but the upregulation was statistically
insignificant. RIG-I is a cytoplasmic viral recognition molecule that activates Type I IFN
responses.
MDP is a bacterial cell wall component that is recognized by NOD-2, and this binding
activates the NF-kB pathway to produce pro-inflammatory cytokines (146).

MDP

stimulation of PPNTECs and PPTECs did not modulate PRRs, cytokines and chemokines
genes except the downregulation of IFN-b gene expression after 24 hours in PPNTECs. A
study conducted on the rat cardiac fibroblast showed that IFN-b can act as both proinflammatory and anti-inflammatory cytokine (147). Overall, MDP’s inability to modulate
PPRs, cytokines and chemokines genes in respiratory epithelial cells may be related to dose
of MDP used for stimulation or nature and physiology of these cells.
iE-DAP is derived from bacterial peptidoglycan and acts as a ligand for the NOD-1
receptor. Upon receptor binding, the NF-kB pathway is activated and leads to the induction
of the inflammatory responses characterized by elevated levels of IL-6 and MCP-1 (148,
149). iE-DAP stimulation of PPNTECs induced significant upregulation of IL-6 after 3
hours. Our findings are consistent with the findings of a study conducted in human alveolar
epithelial cells where they found that iE-DAP treatment of alveolar epithelial cells
increased the expression levels of IL-6 (150). However, after 24 hours of stimulation,
expression levels of IL-6 decreased significantly. Consistent with IL-6, IL-8 and IL-1a
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gene expression also produced similar results. Both IL-8 and IL-1a gene expression were
upregulated after 3 hours of stimulation and downregulated after 24 hours of stimulation,
but the changes were statistically insignificant. IL-6, IL-8, and IL-1a, are proinflammatory
cytokines and it is no surprise to see a similar trend in their gene expression pattern upon
iE-DAP stimulation because iE-DAP causes inflammatory responses through elevated proinflammatory cytokine production via the NF-kB pathway (148, 151). iE-DAP stimulation
of PPTECs produced similar IL-6 gene expression changes as observed in PPNTECs. The
similarity in gene expression patterns between PPNTECs and PPTECs can be attributed to
the similar physiological properties, anatomical proximity, and similar receptor expression.
Poly I:C is a double-stranded viral RNA analog and mimics the dsRNA viral genome. Poly
I:C is detected mainly by TLR-3, and by MDA-5, an RLRs family receptor in a cell-specific
manner. Poly I:C/MDA5 association activates NF-kB pathway through RLR-dependent
signaling pathway and IFN-promoter-stimulator-1 (IPS-1). Similarly, TLR-3 activates the
NF-kB pathway through Toll/IL-1R domain-containing adaptor inducing IFN (TRIF).
Both pathways lead to the activation of Natural Killer (NK) cells (152-154). We stimulated
both PPNTECs and PPTECs with Poly I:C for 3 hours and 24 hours respectively.
After 3 hours of Poly I:C stimulation, TLR-6 gene expression was upregulated
significantly. TLR-6 is known to recognize lipids and is located on the cell surface (155).
Upregulation of TLR-6 upon RNA analog stimulation is hard to explain without further
study. However, none of the other PRRs showed significant changes upon stimulation.
mRNA levels of IFN-B were high on both 3 hours and 24 hours’ time points in both cell
types, but the changes were insignificant. Though statistically insignificant, upregulated
IFN-B gene expression can be attributed to the innate immune responses by these cells.
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IFN-B is produced as a defense mechanism to fight against viral infections. IFNs interfere
with various viral replication stages to halt the replication and stop the viral infection from
growing (156). Like PPNTECs, Poly I:C stimulation caused a huge spike in mRNA levels
of IFN-B after 24 hours in PPTECs, but the change was insignificant.
Poly I:C stimulation of PPTECs had an upregulating effect on TNF-a as TNF-a mRNA
levels were upregulated after 24 hours of stimulation. Association of Poly I:C and TNF-a
have been demonstrated by previous studies. A study conducted in glial cells demonstrated
that Poly I:C stimulated activation of glial cells promoted TNF-a production (157). TNF-a
is one of the cytokines produced as an innate immune defense mechanism during an
infection or invasion.
Poly I:C with lyovec is a complex of Poly I:C and transfection reagent lyovec. Complexing
Poly I:C with lyovec is believed to effectively deliver Poly I:C into the cytoplasm. Unlike
naked Poly I:C which is mainly recognized by TLR-3, transfected Poly I:C is mainly
recognized by RIG-I and MDA-5, and activation of NF-kB proceed through the RIGI/MDA-5 pathway (158). This pathway leads to the production of Type I IFNs against viral
infection. Use of Poly I:C complexed with lyovec has been common and used in multiple
studies like for the stimulation of human lung adenocarcinoma cells (159), human nasal
epithelial cells (160), chicken embryo kidney cells (161). In our lab, previous studies
conducted on bovine and ovine ileal myofibroblast cells (data not published) used Poly I:C
with lyovec for the stimulation assay. In this study, we used Poly I:C with lyovec to
stimulate both PPNTECs and PPTECs.
In PPTECs, Poly I:C with lyovec stimulation caused significant downregulation of TLR-4
and TLR-5 after 3 hours. Both NOD-1 and NOD-2 gene expression levels were also
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downregulated significantly after 3 hours of stimulation by Poly I:C-lyovec complex. Poly
I:C with lyovec stimulation ends up with robust antiviral immune response generation
mediated by the production of Type I IFNs. For TLR-4 and TLR-5, LPS and FLA are the
ligands respectively. For NOD-1 and NOD-2, iE-DAP and MDP are the ligands
respectively. All four ligands are bacterial pathogenic determinants. Because these four
receptors namely TLR-4, TLR-5, NOD1, and NOD-2 are involved in or responsible for the
induction of immune response against bacterial attack, their downregulation upon Poly I:C
with lyovec stimulation is although hard to explain but may signal downregulated
responses to bacterial infections upon viral infections. After 24 hours of stimulation, NOD1 expression was downregulated significantly. Since upregulated NOD-1 is responsible for
activation of NF-kB pathway and production of pro-inflammatory cytokines (148, 149),
this downregulation after 24 hours of stimulation might be important in anti-inflammatory
responses against pathogens including viruses because NLRs have been identified to either
positively or negatively modulate the inflammatory responses. A study has found NOD-1
to be involved in augmenting inflammatory responses. In contrast to our findings,
according to a study, NOD-1 had been found to form a multicomplex protein NODosome
upon their activation and this protein complex then activates IFN and NF-kB pathways to
provide immune responses following a viral infection (162).
As expected, after 24 hours of Poly I:C with lyovec stimulation of PPTECs, MDA-5, which
is one of the receptors for lyovec complexed Poly I:C, upregulated significantly. Consistent
with our findings, previous studies have shown the induction of MDA-5 gene expression
after Poly I:C with lyovec stimulation. A study conducted on human nasal epithelial cells
demonstrated the recognition of RLRs ( RIG-I and MDA-5) by Poly I:C complexed with
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lyovec followed by IFN-b secretion in nasal mucosa (160). Another study conducted on
mice showed that Poly I:C is responsible for the activation of mice's NK cells through
MDA-5 binding and downstream signaling through IPS- 1 (163). Poly I:C lyovec
stimulation for 24 hours produced TNF-a mRNA upregulation on PPTECs. Consistent with
our finding, a study conducted on human bronchial epithelial cells showed a dosedependent increased production of inflammatory cytokines including TNF-a after Poly I:C
activation (164). Similarly, a study conducted on microglial cells has also shown similar
effects (157).
Furthermore, in PPTECs, Poly I:C with lyovec induced significant downregulation of IL1b, IFN-a, and IL-10 after 3 hours of stimulation. However, IFN-a and IL-1b levels were
increased by more than 2 folds after 24 hours, even though statistically insignificant. Both
IL-1b and IFN-a are correlated to inflammation following viral infection (165, 166). Their
initial downregulation and rapid upregulation after 24 hours of stimulation might suggest
that either they need longer stimulation for their activation or the doses of Poly I:C with
lyovec we used were inadequate and took time before these genes were activated. IL-10 is
an anti-inflammatory cytokine (167), just opposite of inflammatory cytokines IL-1b and
IFN-α. In a previous study conducted in our lab on ovine intestinal sub-epithelial
myofibroblasts (ISEMFs), IFN-b expression was increased by at least 150-fold after 24
hours of stimulation (unpublished data). Consistent with the previous study, IFN-b
expression rose by at least 100 folds in this study after 24 hours of stimulation, though the
change was statistically insignificant. The rapid increase in mRNA levels of IFN-b can be
attributed to the generation of a strong anti-viral immune response triggered by Poly I:C
with lyovec stimulation of PPTECs. Surprisingly, no significant changes were observed on
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PPNTECs following Poly I:C with lyovec stimulation at both time points. Even though
PPNTECs and PNTECs share few similarities, we also need to account at what stages the
cells were in during the stimulation assay, their age/passage number, and culture
conditions. These factors along with their innate differences may account for the observed
differences.
Imiquimod is a nucleoside analogue belonging to the imidazoquinoline family. Imiquimod
is sensed by TLR-7 and TLR-8. Recognition of Imiquimod by TLR-7/8 induces activation
of the TLR signaling pathway leading to the activation and nuclear translocation of NF-kB
and production of pro-inflammatory cytokines. The transcribed cytokines activate APCs
and play role in generating the immune response against tumors through T-helper (Th1)
cells (168). However, Imiquimod has been found to work independently of TLR-7/8. In
the adenosine receptor signaling pathway, imiquimod can cause a reduction of adenylyl
cyclase activity independent of TLR-7/8 (169). Moreover, imiquimod, because of its ability
to induce both the innate and adaptive immune response, is seen as a potent vaccine
adjuvant to increase the efficiency of DC-based tumor immunotherapy (170).
Imiquimod stimulation of PPNTECs produced no significant changes on all PRRs tested.
However, even though the change was statistically insignificant, we saw at least a 5-fold
increase in TLR-7 expression only after 3 hours of imiquimod stimulation. Few other TLRs
also showed a similar effect after 3 hours of treatment. We did not test for TLR-7
expression on PPTECs. On PPNTECs, pro-inflammatory cytokines like IFN-a, TNF-a, IL6, and IFN-b and their expression were rapidly upregulated after 3 hours of imiquimod
treatment, but the changes were statistically insignificant. Even though insignificant,
Imiquimod is known to cause the upregulated expression of pro-inflammatory cytokines
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(169). Stimulation of PPTECs produced similar, statistically insignificant, upregulation of
pro-inflammatory cytokines but after 24 hours of imiquimod stimulation.
Inulin acetate nanoparticle (InAc) is a polymer designed for use as a vaccine adjuvant in a
pathogen-mimicking vaccine delivery system (PMDVS) to significantly stimulate the
innate immune system against various diseases. InAc was developed from a plant
polysaccharide called inulin (120). InAc is believed to be an agonist of TLR-4. A study
conducted in mice demonstrated that the use of PMDVS with inulin as the delivery system
caused induction of both the cell-mediated and humoral immune response (171). TLR-4
agonistic property of InAc has been verified in a study conducted with cells like microglial,
dendritic, blood mononuclear, and HEK293 where InAc was able to stimulate the cells
followed by the production of cytokines (172).
In this study, we used InAc to stimulate both PPNTECs and PPTECs at 3 hours and 24
hours’ time points at a concentration of 250 microgram/ml. In PPTECs, InAc stimulation
for 3 hours did not induce any significant changes in gene regulation of the PRRs tested.
Upon 24 hours of stimulation, TLR-4 did upregulate by around 2 folds, but the change was
statistically insignificant. Since InAc is known as a TLR-4 agonist and has been seen
causing induction of TLR-4 mediated signaling (171), the observed upregulation might be
a result of InAc stimulation. In PPTECs, InAc did cause significant downregulation of beta
defensins-1 after 24 hours, but it caused statistically significant upregulation of TNF-a.
Since InAc works through the TLR-4 signaling pathway, the production of TNF-a might
be a result of TLR-4 signaling pathway activation followed by NF-kB activation, and the
production of cytokines like TNF-a. Association between TLR-4 activation and TNF-a
gene expression has been demonstrated in previous studies (173, 174).
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Surprisingly, InAc stimulation of PPNTECs resulted in the downregulation of various
TLRs, NLRS, RLRs, and different cytokines/chemokines after 24 hours. PRRs like TLR1, TLR-2, TLR-3, NOD-2, RIG-I, beta defensins-2, and MDA-5 were significantly
downregulated after 24 hours of InAc stimulation. Similarly, cytokines like IL-10 and IFNa were also downregulated significantly. Such downregulation of PRRs from different
categories could be a result of insufficient dose. Further studies with a higher dose of InAc
is highly recommended and might produce different results.
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4

Conclusions and Future Directions

In this study, the established and characterized PPNTECs and PPTECs were used to
explore their roles in the induction of immune responses upon stimulation by the bacterial
or viral ligands. From the broader perspective, the main goal was to get an insight into how
these cells might react during a pathogenic infection or invasion, and how they modulate
the innate immune response during a disease progression or pathogenesis. Contrary to the
plethora of research on pig intestinal mucosal cells, only a handful of published research
studies have been conducted on pig respiratory mucosal cells, even though respiratory
mucosal cells play an indispensable role in the respiratory immune system and respiratory
disease pathogenesis. To our knowledge, this is the first study conducted on pig respiratory
epithelial cells from the trachea and nasal turbinate of a day-old piglet. Because there’s not
much information about how these cells impact the innate immune system, our study will
provide a better understanding of the involvement of respiratory epithelial cells in the
respiratory immune system and the maintenance of homeostasis in case of a respiratory
infection or invasion.
In this study, pig respiratory epithelial cells obtained from the trachea and nasal turbinate
of a day-old piglet had some fibroblast contamination. A pure culture of pig respiratory
epithelial cells was established by removing fibroblast contamination using the trypsin
treatment method by exploiting their adherence properties. The established pure epithelial
cultures of both PPNTECs and PPTECs, are verified by IHC (cytokeratin expression
>90%) and were immortalized using hTERT and SV-40 large T-antigen. The epithelial
nature of the cells was examined after the immortalization as well, and there were no
significant changes in their phenotypic and biochemical properties. Unlike primary cells,
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immortalized cells grew much faster as indicated by their shorter mean doubling time.
Immortalized cells lines were established successfully as verified by a positive gel image
and an immunofluorescence test for SV40 protein expression for SV40 immortalized cells
and ICC for hTERT cells immortalized with hTERT gene. Along with the primary cells,
these immortalized cells can serve as a good model for use in future studies on pig
respiratory immune system and respiratory disease pathogenesis.
The established PPNTECs and PPTECs were stimulated with various bacterial and viral
ligands to understand their role in modulating the innate immune responses in the
respiratory immune system. Cells were tested for expression/modulation of PRRs like
TLRs,

RLRs,

NLRs,

defensins

along

with

genes

encoding

for

various

chemokines/cytokines at two different time points of 3 hours and 24 hours. After RNA
isolation, cDNA synthesis, and RT-qPCR, CT values were analyzed for changes in gene
expression of various PRRs, cytokines and chemokines genes. Based on data obtained from
RT-qPCR, both cell lines were found to express various PRRs, cytokine and chemokine
genes. Different PRRs gene and their expression were modulated by the bacterial and viral
ligands by either upregulating the gene expression or downregulating it. Not only the PRRs
but the expression of various cytokine/chemokine genes were also modulated after the
stimulation with different bacterial and viral ligands. This is an important finding and will
immensely help future studies on these cells and their role in the respiratory immune
system, and the respiratory disease pathogenesis. Knowing how the cells behave or react
upon stimulation with different pathogenic determinants will certainly help and bolster
future research on these cells to a greater extent. The immortalized PPNTECs and PPTECs
could serve as a continuous cell culture model for the study of respiratory diseases and
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disease pathogenesis. Immortalization wipes out the cell senescence issues and provides
security against the unexpected hindrance of the research work because of the aging of the
primary cells.
Our study was mostly descriptive, and we did not explore the mechanistic details of our
findings especially for the ligand stimulation assay. Our stimulation assay findings are
based on the assumption that any observed changes in the gene expression are directly
caused by the stimulating agents we added without accounting for other possible reasons
for observed changes like culture environment, cellular stages, or any external stress.
Further studies with a focus on mechanistic details are recommended to fully validate our
findings at the molecular level.
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